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Determinants of HIV-1 Gag Localization to Uropods in Polarized T cells 
and the Role Uropods Play in Virus Spread 
 
By 
George Nicholas Llewellyn 
 
Chair: Assistant Professor Akira Ono 
 
HIV-1 is a deadly virus that kills millions of people around the world each year. 
One of the primary targets of HIV-1 in the human body is T cells. In lymphoid organs, 
such as lymph nodes, T cells are highly motile and adopt an elongated or polarized 
morphology. However, little is known about how HIV-1 localizes, assembles or spreads 
in polarized T cells. Thus, determining the molecular mechanisms utilized by HIV-1 in 
polarized T cells can help to understand the virus in vivo. 
Polarized T cells are characterized by a leading edge at the front and a rear end 
protrusion called a uropod. In this thesis, it was determined that the HIV-1 structural 
protein Gag localizes to the uropod in polarized T cells. HIV-1-expressing T cells were 
found to contact uninfected target cells preferentially via uropods relative to leading 
edges. Also, uropods participated in virological synapses that mediate cell-to-cell 
 ix 
transmission of HIV-1. Together, these findings indicate that uropods could play an 
important role in HIV-1 spread in vivo. Mutational analyses were also performed to 
identify the viral determinants of uropod localization of Gag. Nucleocapsid (NC) is a 
structural domain of Gag that binds and packages viral RNA genomes and can promote 
multimerization of Gag by using RNA as a scaffold. NC-mediated multimerization, at the 
level of tetramerization or higher, was found to be required for uropod localization of 
Gag. In identifying the cellular determinants that mediate Gag localization to uropods, 
Gag was found to copatch with some uropod markers (CD43, PSGL-1, CD44) even in 
unpolarized T cells. In contrast, Gag did not copatch with other uropod markers (ICAM-
1, ICAM-3, CD59) in unpolarized T cells. These data, along with live cell analyses, 
indicated that Gag associates with a specific subset of uropod-directed microdomains 
(UDMs) that could carry Gag to the uropod. The specificity of Gag association with 
UDMs was found to be determined by matrix (MA), another structural domain of Gag 
that is responsible for plasma membrane binding. 
The observations made in this thesis suggest a working model of HIV-1 
replication and spread in polarized T cells: When NC-mediated multimerizaton reaches 
the level of tetramerization or higher, Gag associates with specific uropod-directed 
microdomains enriched in CD43, PSGL-1 and CD44 via an MA-mediated mechanism. 
These Gag-associated UDMs then laterally localize on the membrane to the uropod 
where virus particles assemble and accumulate. Uropods then mediate contact and VS 
formation with target cells to facilitate cell-to-cell transmission. 
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CHAPTER I 
Introduction 
HIV-1 genome organization 
 Human Immunodeficiency Virus Type-1 (HIV-1) is an enveloped virus belonging 
to the family Retroviridae. The HIV-1 genome encodes three large polyproteins, two 
regulatory proteins and four accessory proteins. The genome itself is roughly 9KB, and 
expression of the viral proteins requires differential splicing. The three large polyproteins 
are Gag, Pol and Env, the accessory proteins are Vpu, Vif, Vpr, and Nef, and the 
regulatory proteins are Tat and Rev (Fig. 1.1A). 
The transcribed genome of HIV-1 has several splice variants. First, the HIV-1 
polyproteins Gag and Pol are expressed from unspliced viral RNA. Gag is the primary 
structural polyprotein of HIV-1. Gag is composed of four structural domains and is 
sufficient to form virus-like particles[1]. Pol is a polyprotein that is translated as a part of 
a fusion protein (GagPol) by a ribosomal frameshift that occur near the end of the Gag 
sequence. The efficiency of this frameshifting ranges from 0.8-2.4% in cultured 293T 
cells and from 4.6-8.5% in vitro, depending on HIV-1 subtype[2]. The polyprotein Pol 
contains the viral enzymes Protease, Reverse Transcriptase and Integrase. Protease 
cleaves Gag into its four subunits, which is a process required for maturation of the virus 
into an infectious form. Reverse Transcriptase converts the genomic RNA into double 
stranded DNA. After transport into the nucleus, Integrase facilitates incorporation of this 
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double stranded DNA into the host cell chromosome. Unspliced RNA is also used as the 
viral genome and packaged into new virus particles.  
Singly spliced RNA encodes the third viral polyprotein Env and the accessory 
proteins Vpu, Vpr and Vif. Env (gp160) is composed of a surface subunit (gp120) that 
binds to the virus receptor CD4[3] and the co-receptors CCR5 or CXCR4[4-6]. Env also 
contains a transmembrane subunit (gp41) that mediates fusion of the viral and cellular 
membrane during the virus entry process. Env is cleaved into its gp120 and gp41 subunits 
by cellular proteases. Vpu binds to and downregulates CD4[7] and a host restriction 
factor Tetherin[8, 9], facilitating release of the virus from cells. Vpr mediates a delay or 
arrest of infected cells in the G2 phase of the cell cycle[10, 11]. Vif prevents the 
incorporation into virus particles of a cellular restriction factor Apolipoprotein B mRNA 
editing enzyme catalytic polypeptide-like 3G (APOBEG3G)[12], a cytidine deaminase 
that ultimately converts cytosine to uracil in the viral RNA during reverse transcription 
often causing deleterious mutations. 
Finally, doubly spliced RNA encodes the accessory protein Nef, and the two 
regulatory proteins Tat and Rev. Tat enhances transcription by binding to the TAR  (trans 
activating response) element of nascent viral RNA genomes, and stabilizing the 
elongation step as well as recruiting and activating cellular transcription machinery[13]. 
Rev attaches to the Rev Responsive Element (RRE) on unspliced and singly spliced viral 
mRNA transcripts and facilitates their export out of the nucleus where they can be 
translated[14]. Nef has several functions including downregulating CD4 and enhancing 
immune evasion by downregulating MHC class I[15-18].  
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HIV-1 Life Cycle 
This is a general review of the life cycle of HIV-1. For this thesis, the sections discussing 
attachment and virus assembly are the most pertinent to the later chapters.  
 
Attachment and fusion 
The HIV-1 life cycle is illustrated in Fig. 1.2. HIV-1 primarily infects T cells and 
macrophages. The surface of an HIV-1 particle is decorated with a glycosylated protein 
called Env. Env heterodimers (gp120 and gp41) form trimers [19, 20]. Env binds to the 
host cell receptor CD4[3] and a co-receptor, usually CCR5 or CXCR4[4-6] depending on 
the cell tropism of the infecting virus. After attachment, the gp41 subunit of Env 
undergoes a conformational change. This change exposes a fusion peptide[19] that inserts 
into the target cell membrane. The ectodomains of trimeric gp41 then form a six-helix 
bundle that brings the two membranes close enough to mediate fusion[21, 22]. HIV-1 can 
also enter the cell via receptor-mediated endocytosis[23]. However, infection through this 
pathway still requires fusion of the virus with the endosomal compartment. 
 
Uncoating 
 After fusion occurs, the core of the virus is released into the cytosol of the target 
cell. The core is composed of a structural subunit of the Gag polyprotein called capsid 
(CA), which forms a shell around two copies of the viral RNA genome that are bound by 
another subunit of Gag called nucleocapsid (NC). The core also contains Reverse 
Transcriptase. Uncoating of the viral core is required for release of the viral genome.[24, 
25] although the exact timing and mechanism of uncoating are still being investigated. A 
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cellular host restriction factor, tripartite motif-containing protein 5-(TRIM5-), was 
found to bind to the viral core and interfere with the uncoating and reverse transcription 
processes[26]. This interaction inhibits productive infection, indicating that the uncoating 
process is required for HIV-1 replication. To overcome this restriction, HIV-1 has 
evolved mutations in CA, which allow HIV-1 to specifically evade human TRIM5-[27, 
28]Howeverthese CA mutations do not protect the virus against TRIM5-proteins 
from other species. For example, while HIV-1 is insensitive to human TRIM5-, it is 
restricted by non-human primate TRIM5-proteins.  
 
Reverse transcription and nuclear entry 
If the core is successfully uncoated, reverse transcription of the RNA genome into 
double stranded DNA is mediated by the viral enzyme Reverse Transcriptase. It is at this 
stage that another host restriction factor is able to disrupt the virus life cycle. 
APOBEC3G deaminates cytosines to uracils in the minus strand DNA during reverse 
transcription, resulting in GA mutations in the provirus[30, 31]. The HIV-1 viral 
protein Vif overcomes APOBEC3G-mediated restriction by directly binding to 
APOBEC3G and triggering its ubiquitination and degradation[12, 32, 33].  
During and after reverse transcription, the pre-integration complex (PIC), which is 
composed of viral DNA and various viral and cellular proteins, is transported to the 
nucleus. This process is dependent on microtubules[34]. The mechanism by which the 
viral DNA and Integrase enzyme are imported into the nucleus is still under investigation.  
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Integration 
Once inside the nucleus, multimerized Integrase interacts with the cellular protein 
lens epithelium derived growth factor (LEDGF) to mediate integration of the viral DNA 
into a host cell chromosome[35, 36]. This integrated HIV-1 DNA genome is called the 
provirus. It is thought that LEDGF could promote integration specifically to sites of 
active transcription[37, 38], although this is still under investigation.  
 
Transcription and RNA export 
The provirus is transcribed from a 5` promoter in the long terminal repeat (LTR) 
region. The HIV-1 protein Tat promotes transcription from this region, specifically by 
binding the cis-acting TAR element of the nascent viral RNA transcripts and recruiting 
chromatin remodeling complexes[39, 40]. Tat also recruits positive transcription factors 
such as p-TEFb that phosphorylate and activate DNA polymerase II (Pol II). Pol II then 
binds the TATA box of the promoter and transcribes the DNA[41]. Tat is also known to 
enhance initiation and elongation[42, 43]. Doubly spliced RNA that encodes the viral 
accessory proteins Tat, Rev and Nef are exported to the cytosol where they are translated. 
Export of the full HIV RNA genome to the cytosol requires the Rev protein, which 
oligomerizes and interacts with the Rev response element (RRE) sequence[40, 44] as 
well as the nuclear export protein CRM/Exportin 1 to transport the RNA out of the 
nucleus[45]. Once enough Rev is made, export of the viral genome can occur and 
translation and assembly of virus particles ensues. 
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Assembly 
The primary structural protein of HIV-1 is a 55kD precursor polyprotein called 
Pr55
Gag
(Gag), which contains four structural domains. These structural domains, in order 
from N to C-terminus, are matrix (MA), capsid (CA), nucleocapsid (NC) and p6[1, 46] 
(Fig. 1.1B). MA encodes a myristoylation signal at its N-terminus and a highly basic 
region (HBR), both of which mediate plasma membrane targeting and binding of 
Gag[47-52]. The myristate moiety is cotranslationally added to the N-terminus of Gag 
and is normally sequestered inside MA. Exposing the myristate is mediated by 
trimerization of Gag in a process called the myristoyl switch[49]. The myristate is 
inserted into the plasma membrane and increases membrane binding. Targeting of Gag to 
the plasma membrane also requires an interaction between the HBR and a plasma 
membrane phospholipid phosphatidylinositol-(4,5)-bisphosphate  [PI(4,5)P2][50, 53, 54]. 
This interaction was determined both by NMR studies and by observing Gag 
mislocalization after treatment of cells with 5phosphataseIV, which depletes 
PI(4,5)P2[50, 53, 54].. Membrane binding of Gag is also regulated by RNA interactions 
with the HBR[55].  
Assembly of virus particles requires multimerization of Gag on the plasma 
membrane. Multimerization of Gag is mediated by its CA and NC domains. CA mediates 
multimerization through a dimerization interface within the C-terminal domain of CA. 
The residues W184 and M185 are critical for dimerization within this interface[56-61]. 
NC-mediated multimerization is driven by NC utilizing RNA as a scaffold. This is 
supported by experiments in which 1) a loss of Gag multimerization was observed when 
NC was mutated, 2) RNA was required to induce Gag multimerization in vitro, and 3) 
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RNAse treatment disrupts Gag-Gag interactions in another retrovirus, MLV[56, 58, 62-
65]. Gag multimerization induces plasma membrane curvature to form virus particles.  
 
Viral genome packaging 
During HIV-1 assembly, the viral RNA genome is packaged as a dimer. Genomic 
RNA dimerization is mediated by a “kissing loop” sequence on both RNAs that 
specifically interact[66]. This sequence is located within the packaging signal (This 
signal is composed of four stem loops at the 5` end of the viral RNA genome. Packaging 
of the viral RNA into virus particles is mediated by NC. The specificity of viral RNA 
packaging by NC, as opposed to most cellular RNA that can also be bound by NC, is 
mediated by two zinc finger motifs within NC. These zinc fingers recognize and bind the 
packaging signal[67]. Some cellular RNAs have been found to be randomly 
packaged[68], while others cellular RNAs such as the small signal recognition particle 
RNA 7SL[69, 70] are specifically enriched in virus particles. However, the function of 
these cellular RNAs in virus replication is unknown. 
 
Virus release and maturation 
In order for newly formed virus particles to be released from the cell, the cellular 
ESCRT complex is required. The ESCRT complex facilitates final scission of virions 
from the plasma membrane[71-74]. The ESCRT complex is recruited by the virus via an 
interaction between the ESCRT protein TSG101 and the PTAP motif within the p6 
domain of Gag[72, 74-76]. The final release of virus particles from the plasma membrane 
is inhibited by a cellular host restriction factor tetherin[8, 9] through direct binding of 
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tetherin to virus particles[77-79]. Tetherin restricts the release of several different 
retroviruses, but the determining how Tetherin mediates restriction of these unrelated 
viruses is still under investigation. To circumvent tetherin restriction, HIV-1 encodes 
Vpu[8, 9]. Vpu can bind to tetherin and both remove it from assembly sites and cause its 
degradation[80, 81]. Another block on the release of virions is the presence of CD4 on 
the plasma membrane. Even though CD4 is the virus receptor, and is required for 
attachment and entry of HIV-1, it can also decrease virus release by binding the Env of 
budding particles. HIV-1 overcomes this restriction by downregulating CD4 with both 
Nef and Vpu[7, 18] after the cell is infected. Nef also overcomes another source of virus 
restriction by downregulating MHC class I (MHC-I) on the cell surface[15, 16]. MHC-I 
presents viral antigens to cytotoxic T lymphocytes that would kill the infected cell.  
While Gag is sufficient to form virus-like particles (VLPs)[46], several other 
proteins are required for a virus particle to be infectious. For example, after an HIV-1 
particle is released, Protease cleaves Gag into its component structural subunits MA, CA, 
NC and p6 in a process known as maturation. This process is required for a particle to be 
infectious. During maturation, MA forms the outer shell under the HIV-1 membrane and 
provides the virus with structure. CA forms the virus core that encapsulates the viral 
genome and enzymes. NC binds to the viral RNA and protects it from degradation by 
nucleases[82]. Env should be incorporated into virus particles for progeny virions to 
become infectious. Env incorporation is thought to be mediated by a direct interaction 
between the cytoplasmic tail of Env and MA[83-85]. However, other factors could also 
be involved in Env incorporation as well. For example, the cellular protein TIP47 has 
been observed to bind the cytoplasmic tail of Env and is also implicated in its 
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incorporation into virus particles[86]. Finally, a cellular protein, cyclophilin A, has been 
observed to be incorporated into virus particles and has been implicated in early steps of 
virus replication[87, 88]. Cyclophilin A has also been observed to substantially increase 
virus infectivity[88, 89].  
 
HIV-1 and Microdomains 
 The plasma membrane does not contain a homogenous distribution of proteins 
and lipids. Rather, certain lipids and proteins cluster together in submicroscopic groups 
called microdomains[90]. Two subgroups of microdomains are lipid rafts and 
tetraspanin-enriched microdomains (TEMs). Lipid rafts are enriched in cholesterol and 
glycosphingolipids. Lipid rafts are thought to be dynamic and unstable, with lipid raft 
proteins rapidly associating and dissociating[91]. Functionally, lipid rafts are thought to 
serve as platforms for the concentration of proteins to enhance their function in several 
cellular processes including signaling, protein sorting and cell polarity. Lipid rafts are 
also important for HIV-1 assembly[92-95]. For example, it was found that HIV-1 Gag is 
present in detergent resistant membranes (DRMs) and DRM association is considered an 
indication that a protein is enriched in lipid rafts[93-95]. Also, depleting cholesterol, 
which disrupts lipid rafts, was found to inhibit Gag membrane binding and virus release 
of HIV-1[94]. 
TEMs form when a group of transmembrane proteins called tetraspanins homo- or 
hetero-oligomerize and recruit other cellular proteins into clusters on the membrane. Gag 
has been observed to colocalize with several TEMs, including CD9, CD63, CD81 and 
CD82[96]. TEMs have also been observed to play a role in HIV-1 viral processes. 
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Specifically, knockdown of the tetraspanin CD81 was observed to increase HIV-1 cell-to-
cell transmission[97]. Tetraspanins have been found to be enriched in virological 
synapses[98] and prevent Env-mediated cell-cell fusion[99]. Interestingly, while 
knocking down CD81 decreased virus release, it also increased virus infectivity[100]. In 
contrast, others have found that some TEMs inhibit virus infectivity. Conceivably, this is 
why TEMs appear to be regulated by HIV-1 and show some reduction in infected 
cells[97]. Thus, TEMs could serve both positive and negative functions in the life cycle 
of HIV-1. Further study of TEMs is required to understand their role in virus replication. 
As mentioned above, microdomains such as lipid rafts are submicroscopic, 
measuring only 10-20nm. Thus, lipid rafts are much smaller than the limit of resolution 
for standard fluorescence microscopy (250nm)[91]. Thus, the optical techniques used to 
study microdomains have been indirect, and some believe they are potentially 
flawed[101, 102]. For example, antibody-mediated crosslinking of surface proteins 
induces stabilization of the microdomains they associate with. This stabilization 
facilitates formation of larger clusters or patches of microdomains that can be observed 
by standard fluorescence microscopy. Thus, if two proteins are antibody-crosslinked, the 
amount of “copatching” between the two should indicate whether they associate with the 
same microdomain. This copatching assay has been frequently used to determine whether 
two proteins have a propensity to associate with the same microdomain[103-109]. 
However, it has been argued that because this is not the native state of the proteins on the 
cell surface, any conclusions about microdomain association should be treated 
skeptically. Classifying whether a protein is lipid raft-associated has also been 
determined biochemically by observing whether that protein partitions into non-ionic 
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detergent-resistant membrane (DRM) fractions. The rationale is that lipid rafts that 
contain tightly packed lipids and proteins should be more resistant to detergent treatment 
than the rest of the plasma membrane and remain intact. These DRMs then float on a 
sucrose gradient and can be analyzed by western blot. This assay has also been used to 
determine that HIV-1 Gag associates with lipid rafts[92-94, 110-112]. However, the 
conclusions about lipid raft association of proteins based on this assay are also subject to 
debate because the results depend heavily on the strength of the detergent. Also, it has 
been observed that one of the detergents used in the assay, Triton X, induces formation of 
solid patches on the membrane[113]. If so, the detergent resistance of some proteins 
could be an artifact of the detergent treatment itself. Finally, although their relative 
sensitivities to detergent are different, both lipid rafts and TEMs have been found to 
reside in DRMs[114-116]. However, while these concerns should be considered, it should 
also be noted that there have been recent advances in biophysical analysis and new 
microscopy techniques, such as super resolution microscopy that can observe fluorescent 
patches at a 10-30nm resolution. This resolution allows visualization of the native state of 
microdomains, and studies using this technique have lent support to the microdomain 
model and corroborate copatching analyses[91, 117-119].  
Currently, not only lipid-lipid interactions, but also protein-protein and protein-
lipid interactions, are thought to be important for microdomain formation [119, 120]. 
Relevant to this thesis, multimerizing proteins are thought to stabilize or recruit 
microdomains[121, 122]. HIV-1 Gag multimerizes on the plasma membrane, and this 
multimerization has been observed to be important for microdomain association[93, 123]. 
Multimerization could also allow Gag to associate with specific microdomains, and/or 
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reorganize the membrane by recruiting other microdomains. Recent observations by 
Hogue et al. on this field are discussed below[124]. Still, the function and even the 
definition of what constitutes a membrane microdomain require further study.   
Other microdomains have also been associated with HIV-1. For example, the 
Gould group has observed that Gag localizes to exosomes/microvesicles (EMVs), also 
called endosome-like domains (ELDs), from which exosomes are secreted[123, 125]. 
They also show that multimerization and membrane binding is sufficient to drive ELD 
association of a cytoplasmic protein such as Gag [123]. These observations define a 
specific microdomain with which HIV-1 Gag associates and show that multimerization is 
sufficient to drive this localization. This study also shows that associating with ELDs 
facilitates polarization of those proteins. Interestingly, one of the proteins enriched in 
ELDs is the tetraspanin CD63, suggesting that ELDs could represent the same Gag-
associated microdomains discussed above. These studies provide additional supporting 
evidence for the working model developed in this thesis detailed below and in the 
following chapters. 
TEMs and lipid rafts are distinct microdomains that do not colocalize with each 
other. However, as just discussed, both TEMs and lipid raft markers have been shown to 
colocalize with HIV-1 Gag. An interesting development came from recent work in which 
HIV-1 was observed to coalesce these segregated microdomains together[126] in a step-
wise manner[124]. Therefore, it appears that Gag may form its own microdomain by 
recruiting various cell-surface proteins and microdomains. Work done in this thesis 
provides insights into uropod-directed microdomains (UDMs) that are enriched in Gag 
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and several uropod-associated proteins in infected T cells. The mechanism by which Gag 
associates with or recruits a specific subset of these UDMs is also investigated. 
 
Cell-to-cell transmission 
 The model of HIV-1 spread that is often described involves HIV-1 virions being 
released from infected cells after which they travel in extracellular space until they come 
in contact with a target cell. However, this cell-free transmission route has proven to be 
highly inefficient[127]. Alternatively, another mode of HIV-1 transmission can occur 
when an infected cell contacts a target cell and directly transfers the virus. This process is 
called cell-to-cell transmission. In contrast to cell-free transmission, cell-to-cell 
transmission of HIV-1 is 10 to several thousand fold more efficient in cultured T cells, 
and is believed to be the major form of transmission for HIV-1 as well as several other 
viruses[127-130]. The efficiency of cell-to-cell transmission of HIV-1 was elegantly 
shown by the Schwartz group, which measured spreading of virus from infected to 
uninfected cells with or without shaking the cultures. The shaking prevented prolonged 
contacts between T cells from forming, but not the amount of virus particles released, 
thus imitating cell-free transmission. Under shaking conditions, the amount of virus 
spread was found to be minimal compared to without shaking, indicating that cell-cell 
contacts were vital for the spread of the virus[127].  
Cell-to-cell transmission occurs among T cells, dendritic cells, macrophages and 
other cell types capable of harboring replicating HIV-1[131-135]. For example, in 
addition to transmission between T cells, cell-to-cell transmission can also occur between 
T cells and dendritic cells (DCs)[131, 132, 135]. DCs are not efficiently infected by HIV-
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1, but they are well known to pass the virus laterally to T cells via cell-to-cell 
transmission. The contacts formed between T cells and dendritic cells are sometimes 
called “infectious synapses.” The adhesion molecule ICAM-1 has been observed to be 
concentrated at this junction and found to be important for transfer of virus particles from 
DCs to T cells[136]. Interestingly, and relevant to this thesis, ICAM-1 interaction with its 
binding partner LFA-1 is also implicated in HIV-1 transfer between T cells[137, 138]. 
Other viruses utilize cell-to-cell transmission to facilitate their spread as well, including 
another retrovirus that replicates in T cells, human T-lymphotropic virus 1 (HTLV-
1)[134, 139-141]. This observation indicates that cell-to-cell transmission is a common 
means of virus spread among retroviruses. Structurally, cell-to-cell transmission is 
thought to occur through several mechanisms including traveling along cytonemes or 
nanotubes or through virological synapses (VSs) that resemble immunological synapses 
(ISs).  
Cytonemes, Latin for “cell thread,” are thin membranous extensions that connect 
cells together. Cytonemes have been observed to allow particles of Murine Leukemia 
Virus (MLV), another retrovirus, to travel from infected to uninfected cells[142-144]. 
Recent live cell imaging showed fluorescently labeled MLV particles appearing to travel 
along the outside of these long-lived cytoneme protrusions to the target cell. This 
observation was also made for HIV-1 and avian leukosis virus (ALV), indicating a 
common transmission pathway for retroviruses in general. However, these studies were 
conducted using two adherent cell lines as the donor (COS-1) and target (XC) cells[142-
144]. Thus, the contribution of cytoneme-mediated transfer to HIV-1 transmission 
between T cells is unknown.  
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 Nanotubes are closed, actin-filled structures that form when T cells contact each 
other and pull away. HIV-1 appears to be able to travel on the outside of these nanotube 
protrusions from infected cells to target cells[145]. Because these structures were 
observed between cultured T cells, they represent a possible mechanism for cell-to-cell 
spread of HIV-1 in the body. However, it has yet to be determined whether either 
nanotubes or cytonemes are formed between T cells in vivo.  
HIV-1 cell-to-cell transmission also occurs at contact junctions formed between 
infected and uninfected T cells, which are called virological synapses (VSs)[98, 130, 131, 
133, 138, 146-150] due to morphological similarities to immunological synapses. 
However, recent 3D electron microscopy images have shown that the VS, unlike the IS, 
is very porous and does not hide viruses from most antibody attacks[147, 151]. 
Structurally, the VS is enriched in both viral proteins and receptors. The VS is also 
enriched in TEMs, lipid raft markers as well as adhesion molecules such as LFA-1[97, 
98, 130, 138, 149]. The function of these proteins could be to stabilize the VS, although 
this is still under investigation.  
VSs may be common to many retroviruses. For example, this structure was first 
described for another retrovirus, human T-lymphotropic virus 1(HTLV-1)[134], which 
was also the first discovered human retrovirus and is propagated solely by cell-to-cell 
transmission. In the case of HIV-1, VS formation is mediated by the Env-CD4 
interaction[152, 153]. One reason virus spread at the VS may be more efficient than cell-
free transmission is that, unlike cell-free transmission, the VS is capable of promoting the 
simultaneous transfer of numerous virus particles[146, 154]. Consistent with this, it has 
been found that many more copies of the HIV-1 provirus are integrated into the DNA of 
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infected cells under cell-to-cell transmission compared to cell-free transmission[154]. 
Thus, cell-to-cell transmission could explain the high number of proviruses detected in 
the cells of patient samples[155]. The increased number of infection events mediated by 
cell-to-cell transmission also appears to allow HIV-1 to replicate even in the presence of 
antiviral drug therapy[156]. Furthermore, the virus particles transferred to target cells via 
virological synapses can be endocytosed, with maturation occurring inside the endosomes 
of the target cell. This process can protect the virus from some antibodies targeted to 
mature particles[157]. 
 
Mechanisms of VS formation 
While the mechanism of VS formation remains an active subject of study, 
previous observations indicate that cytoskeletal components and lipid raft integrity are 
important for VS stability and formation[130, 150, 158]. For example, virological 
synapses require accumulation of the virus receptor CD4 and coreceptors, which depends 
on actin[159]. Also, polarization of HIV-1 Env appears to be dependent on the 
microtubule cytoskeleton[150, 160]. Another cellular protein important for cell-to-cell 
transmission is Zap70. Zap70 is known to regulate IS formation and cell polarization by 
controlling cytoskeletal rearrangement and localization of the microtubule organizing 
center (MTOC)[161]. In the absence of Zap70, HIV-1 infected cells were found to form 
less VSs and cell-to-cell transmission was decreased[162]. These observations indicate 
that the cellular cytoskeleton is a vital component of VS formation and cell-to-cell 
transmission. Because the cellular cytoskeleton can determine lateral localization of 
proteins on the plasma membrane, it is conceivable that the role of the cytoskeleton could 
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be to facilitate lateral movement of HIV-1 components to the virological synapse. 
Consistent with this, it has been observed that HIV-1 Gag can be recruited over the cell 
surface to the VS after contact is made[146, 149].   
The multitude of studies of virological synapses and their role in cell-cell 
transmission indicate that the VS plays a major role in the spread of HIV-1. However, the 
relationship between biologically relevant polarized T cells and virological synapses has 
not been examined. Therefore, this thesis explored the role of polarized T cells in 
virological synapses and cell-cell transfer of virus particles. 
 
Uropods 
Two-photon imaging studies have shown that a majority of T cells in lymph 
nodes are highly motile and have a polarized or “hand-mirror” morphology[163-168]. 
The front end of a polarized T cell is called the leading edge, and there is a characteristic 
protrusion at the rear called a uropod[169-171].(Fig. 1.3) The uropod is a feature 
common to several cell types including T and B lymphocytes, natural killer (NK) cells, 
neutrophils, monocytes, granulocytes and dendritic cells[170, 171].  
The protrusion of the leading edge is mediated by the small G proteins Rac1, 
Rac2 and CDC42 that regulate the actin cytoskeleton[172]. For uropod formation, F-actin  
and uropod-associated proteins are first enriched at one end of the cell[173]. This pole is 
called the polar cap and is the precursor to uropod formation. F-actin forms filaments in 
parallel to the long axis of migration. This pattern of F-actin is consistent with the 
localization pattern of the highly homologous Ezrin/Radixin/Moesin (ERM) proteins. 
ERM proteins bind and promote polarization to the polar cap of several uropod proteins 
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including CD43, CD44, P-selectin glycoprotein ligand-1(PSGL-1), Inter-Cellular 
Adhesion Molecule (ICAM)-1, ICAM-2, and ICAM-3[174-176] The N-terminal domain 
of ERMs, called the FERM domain, binds both PI(4,5)P2 and the cytoplasmic tails of the 
aforementioned uropod proteins[177]. PI(4,5)P2 binding then causes a conformational 
change revealing a phosphorylation site that, when phosphorylated, promotes ERM 
binding to the actin cytoskeleton via an actin binding domain. This linking of uropod 
proteins to the actin cytoskeleton facilitates localization of these proteins to the polar 
cap[174-176]. ERM-mediated localization of these proteins to the polar cap also depends 
on myosin motor proteins. Protrusion of the polar cap, which leads to formation of the 
uropod, is mediated by actin rearrangement through RhoA and its downstream effector 
Rho-p160 coiled-coil kinase (ROCK).[171, 172]. Thus, the ROCK inhibitor Y-27632 
depolarizes cells but does not inhibit capping[178], while the myosin light chain kinase 
inhibitor ML7 morphologically depolarizes cells and disperses uropod proteins[179].  
Polar caps that are precursors to uropods also serve an important role in T cell 
signaling and function. The uropod protein PSGL-1 binds to a family of adhesion 
molecules called selectins. PSGL-1 primarily binds to P-selectin[180-182] that is usually 
expressed in endothelial cells. However, PSGL-1 can also bind to L-selectin that is 
expressed on other T cells[183, 184]. The interaction between PSGL-1 and P-selectin is 
the first signal for a T cell in the blood to slow down and start rolling on endothelial cell 
venules. Crosslinking of PSGL-1 sends signals through its cytoplasmic tail that stimulates 
a Syk-dependent pathway, leading to a conformational change in another major adhesion 
molecule LFA-1. This signaling pathway leads to an increase in the avidity of LFA-1 to 
ICAM-1 that further slows T cell rolling velocity[185, 186]. Chemokine signals then 
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promote further conformation changes that strengthen the LFA-1 interaction with ICAM-
1 to arrest cell movement. It is at this step that polarization and uropod formation become 
necessary for the migration of T cells into the tissue in a process called extravasation. T 
cells then follow chemotactic signals, especially from CCL21[187].  
The uropod can be identified in several ways. For example, uropods are enriched 
in several cell-surface adhesion molecules including PSGL-1, CD44, CD43, ICAM-1, 
ICAM-2 and ICAM-3[170, 188-190] and lipid raft markers such as GM1 and CD59[92, 
191]. Immunostaining of these proteins can be used to identify uropods in polarized T 
cells. Uropods can also be identified by the location of the microtubule organizing center 
(MTOC) that localizes to the base of uropod protrusions. Microtubules are thought to 
increase the deformability of the cell and increase migration through tight spaces[171, 
187]. However, disruption of microtubules does not inhibit uropod formation, in fact it 
promotes it[192, 193]. Finally, the uropod also features microspikes and microvilli, 
which are actin-based protrusions known to promote attachment to other cells[179, 190, 
194]. In this thesis, uropods are identified primarily by observing the localization of 
PSGL-1, CD43 and the location of the MTOC. 
Functionally, uropods play a role in T cell migration by facilitating deadhesion of 
adhesion molecules such as LFA-1 that mediates substrate adhesion at the leading edge. 
While T cell migration, uropods also mediate contact with other T cells[195] and recruit 
bystander T cells to sites of inflammation[196]. Because the uropod is identified in this 
thesis as the cell structure to which HIV-1 Gag localizes in polarized T cells, these 
uropod-mediated contacts between T cells could be taken advantage of by HIV-1 in order 
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to facilitate its spread in vivo. Thus, the role that cell polarization and uropod localization 
of HIV-1 play in cell-to-cell transfer of the HIV-1 was investigated in this thesis. 
 
Thesis Rationale 
HIV-1 infects and kills millions of people every year worldwide. In 2010, 34 
million people were living with HIV/AIDS. There were 2.6 million new infections, most 
of which occurred in Africa. Over 48,000 of these new infections occurred in the United 
States as well[197]. Most patients who undergo treatment for HIV-1 take a cocktail of 
anti-HIV-1 drugs in a regimen called highly active anti-retroviral therapy (HAART). 
Currently, HAART usually includes a cocktail of drugs that target reverse transcription 
(RTIs) and prevent virus maturation by inhibiting protease (PIs). However, drugs that 
target fusion of the envelope with the plasma membrane (fusion inhibitors) and 
integration of the viral genome into the host cell DNA (Integrase inhibitors) have also 
been developed. Although HAART controls viral loads very well, low levels of virus 
replication can still occur in the body despite therapy[198, 199]. This low-level virus 
replication can eventually lead to drug resistant mutations. Also, when patients 
discontinue HAART therapy, their viral loads rapidly rebound[199-202]. Thus, while 
HAART has improved the lives of millions of those living with HIV-1, it is not a cure. 
Currently there is no vaccine or treatments available that cure HIV-1. Thus, further 
studies into basic HIV-1 biology, especially how HIV-1 replicates and spreads in vivo, 
are required to determine potential new therapy avenues.  
As mentioned, current drugs are able to target fusion, reverse transcription, 
integration and maturation, but there are no inhibitors of several late HIV-1 assembly 
 21 
steps such as plasma membrane binding or multimerization of Gag. The majority of HIV-
1 transmission between cells in the body likely occurs through direct cell-cell contact, yet 
there is also much that is not understood about how this process occurs in vivo and 
whether drugs need to be tailored better to combat cell-to-cell transmission. For example, 
cell-cell transmission has been observed to decrease sensitivity to drug treatment[156], 
which could affect the long-term control of virus by HAART therapy in patients.  
T cells in lymphoid organs, where cell-to-cell transmission likely occurs, are 
constantly migrating and adopting a polarized morphology. However, virological 
processes, including cell-to-cell transmission, have not been studied in the context of 
polarized T cells. Therefore, determining how Gag localizes on the plasma membrane in 
polarized T cells, and the role polarized T cells play in virological processes such as cell-
to-cell transmission, would lead to a better understanding of basic HIV-1 biology in vivo.  
This could potentially lead to new drug targets to combat HIV-1. In this thesis it is shown 
that HIV-1 Gag localizes to uropods in polarized T cells. Therefore, the goal of this thesis 
is to investigate the role that uropods play in cell-to-cell spread of HIV-1 and the viral 
and cellular determinants of uropod localization of HIV-1 Gag. 
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Figure 1.1. HIV-1 genome and Gag organization.  
A) Illustration of the HIV-1 genome. HIV-1 encodes 9 proteins generated by differential 
splicing. Unspliced RNA encodes two of the primary proteins Gag and Pol and is 
packaged as the viral genome. Singly spliced RNA encodes the third primary protein Env 
and the accessory proteins VPU, VPR and VIF. Doubly spliced RNA encodes the fourth 
accessory protein Nef, and the two regulatory proteins Tat and Rev. B) The structural 
polyprotein Gag is composed of four structural domains that are cleaved by protease, 
MA, CA, NC, and p6. Gag contains four functional domains before it is cleaved. MA 
mediates membrane binding. CA and NC mediate multimerization. NC also binds and 
packages viral RNA. p6 recruits cellular ESCRT machinery to facilitate release of viral 
particles from cells. The diagrams were adapted from the thesis of Ian Hogue, 2010 and 
Vineela Chukkapalli, 2011. 
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Figure 1.2. The HIV-1 life cycle. 
HIV-1 attaches to the cell membrane via an interaction between viral Env protein and the 
receptor CD4 and coreceptor CCR5 or CXCR4. Fusion of the HIV-1 and plasma 
membranes releases the genomic RNA into the cytosol. The RNA genome is reverse 
transcribed into double stranded DNA, transported into the nucleus and integrated into 
the host cell DNA. This proviral DNA is then transcribed, spliced and exported out of the 
nucleus where it is translated into viral proteins. The primary structural protein Gag 
recruits unspliced viral RNA genomes, binds the plasma membrane and multimerizes. 
Multimerizing Gag causes membrane curvature and the formation of nascent virus 
particles. Cell machinery is recruited by Gag to facilitate the release of the virions from 
the cell. After release, the viral protease cleaves Gag into components that form the 
mature and infectious virus. The illustration was adapted from the thesis of Ian Hogue, 
2010. 
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Figure 1.3. Morphology and characteristics of a polarized T cell. 
Migrating T cells become morphologically polarized and form two ends. A leading edge 
at the front and a rear end protrusion called a uropod. The leading edge is enriched in 
chemokine receptors and the adhesion molecule LFA-1 and drives the direction of 
migration by sensing chemotactic signals. The rear end uropod is enriched in adhesion 
molecules, PSGL-1, CD43, CD44, ICAM-1, ICAM-2, and ICAM-3 and lipid raft 
markers such as CD59 and frequently mediates cell-cell contacts. The microtubule 
organizing center also localizes to the base of the uropod. The illustration was adapted 
from Sanchez-Madrid and Serrador, Nature Reviews Cell Biology, 2009.
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Chapter II 
 
Nucleocapsid Promotes Localization of HIV-1 Gag to Uropods that 
Participate in Virological Synapses between T Cells 
 
Abstract 
T cells adopt a polarized morphology in lymphoid organs, where cell-to-cell 
transmission of HIV-1 is likely frequent. However, despite the importance of 
understanding virus spread in vivo, little is known about the HIV-1 life cycle, particularly 
its late phase, in polarized T cells.  Polarized T cells form two ends, the leading edge at 
the front and a protrusion called a uropod at the rear. In this chapter, using multiple 
uropod markers, it was observed that HIV-1 Gag localizes to the uropod in polarized T 
cells. Infected T cells formed contacts with uninfected target T cells preferentially via 
HIV-1 Gag-containing uropods compared to leading edges that lack plasma-membrane-
associated Gag. Cell contacts enriched in Gag and CD4, which define the virological 
synapse (VS), are also enriched in uropod markers. These results indicate that Gag-laden 
uropods participate in the formation and/or structure of the VS, which likely plays a key 
role in cell-to-cell transmission of HIV-1. Consistent with this notion, a myosin light 
chain kinase inhibitor, which disrupts uropods, reduced virus particle transfer from 
infected T cells to target T cells. Mechanistically, it was observed that Gag copatches 
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with antibody-crosslinked uropod markers even in non-polarized cells, suggesting an 
association of Gag with uropod-specific microdomains that carry Gag to uropods. 
Finally, localization of Gag to the uropod was determined to require higher-order 
clustering driven by the NC domain. Taken together, these results support a model in 
which NC-dependent Gag accumulation to uropods establishes a preformed platform that 
later constitutes T-cell-T-cell contacts at which HIV-1 virus transfer occurs.  
 
Introduction 
One of the primary natural targets of HIV-1 is the T cell. HIV-1 spread between 
infected and uninfected T cells likely occurs frequently in densely packed environments 
such as lymph nodes in vivo. Two-photon imaging studies have shown that a majority of 
T cells in lymph nodes are highly motile and have a polarized morphology [1-6]. 
Therefore, it is likely that, in lymphoid organs, HIV-1 replicates within and is transmitted 
by polarized T cells. However, the life cycle of HIV-1 in polarized T cells has not been 
examined in detail.  
HIV-1 assembly occurs at the plasma membrane and is driven by the HIV-1 
polyprotein Gag. Gag is the primary structural protein of retroviruses, including HIV-1, 
and is both necessary and sufficient for formation of virus-like particles [7]. HIV-1 Gag 
is composed of four structural domains: matrix (MA), capsid (CA), nucleocapsid (NC) 
and p6. MA mediates Gag targeting and binding to the plasma membrane, primarily 
through the myristoyl group on the N terminus of MA, which inserts into the plasma 
membrane, as well as MA basic amino acids that interact with phosphatidylinositol-4,5-
bisphosphate [PI(4,5)P2], a plasma-membrane-specific phospholipid [8-20]. CA mediates 
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Gag dimerization through an interface in its C terminal domain (CTD), in which amino 
acids W184 and M185 play key roles [21-33]. NC binds specifically to the viral genomic 
RNA, which is essential for packaging of viral genomes to virions [34]. In addition, NC 
contributes to multimerization of Gag, whereby RNA is thought to serve as a scaffold 
[21, 25, 28, 35-43]. p6 contains peptide sequences that recruit cellular endosomal sorting 
complex required for transport (ESCRT) proteins, which facilitate the release of virus 
particles [44-46]. 
A polarized T cell forms a leading edge at the front and a protrusion called a 
uropod at the rear [47-49]. There are several proteins known to be enriched in the uropod, 
including intercellular adhesion molecule (ICAM)-1, -2, and -3, P-selectin glycoprotein 
ligand (PSGL)-1, CD43, and CD44 [50, 51]. The microtubule organizing center (MTOC) 
is also known to localize to the base of the uropod [49, 52]. Previous studies have 
observed that in T cells and monocytes, HIV-1 proteins localize to a cell protrusion, 
which resembles a uropod [53-57]. Furthermore, virus particles are enriched in several 
uropod-associated proteins, such as ICAM-1, ICAM-2, CD43 and CD44 [58, 59]. A raft-
associated lipid known to localize to uropods, GM1 [60], also associates with virus 
particles [54, 61, 62]. Altogether, these observations suggest that uropods potentially 
serve as sites of virus assembly in polarized T cells. However, the nature of Gag 
localization in polarized T cells and its significance to virus spread have yet to be fully 
determined. 
T cell uropods have been shown to mediate contact between T cells and other 
cells, which is consistent with the observation of adhesion molecule enrichment in 
uropods [63-65]. Thus, it is possible that HIV-1 accumulation at the uropod may play a 
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role in cell-to-cell transmission. Cell-to-cell transmission is ten to several thousand times 
more efficient than cell-free transmission [53, 57, 66-71]. Recent studies have described 
specific cell contact structures that facilitate cell-to-cell transmission [67, 72-86]. Live 
cell imaging studies have revealed that particles of HIV-1 and murine leukemia virus 
(MLV) are transferred from infected cells to uninfected target cells along the surface of 
filamentous extensions called membrane nanotubes and cytonemes [80-82, 87, 88]. 
Virological synapses (VS), which appear to structurally resemble immunological 
synapses [77, 78, 89-97], are also thought to facilitate the direct transfer of budding virus 
particles from one cell to another [53, 67, 71, 78, 80, 95]. However, the mechanisms 
leading to the establishment of these transmission routes, especially the VS, remain to be 
elucidated.  
 In this chapter, it was determined that the uropod is the cell structure to which 
membrane-associated Gag accumulates in polarized T cells. Gag-containing uropods 
mediated frequent contact with uninfected target cells. Virtually all observed VS, defined 
by accumulation of CD4 and Gag to cell contacts, showed enrichment of the uropod 
marker CD43, suggesting a major role for HIV-1 localization to the uropod in virus 
spread. Consistent with this possibility, upon disruption of uropod formation, cell-to-cell 
transfer of HIV-1 was significantly reduced. Gag on the cell surface copatched strongly 
with uropod markers not only in polarized T cells but also in non-polarized T cells. Gag-
containing patches that were dispersed on the membrane of non-polarized cells appeared 
to move laterally and to concentrate at the uropod when cells became polarized. These 
patches maintained colocalization with uropod markers, suggesting that uropod-directed 
microdomains play a role in polarized Gag localization. Uropod localization of Gag 
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required higher-order multimerization or clustering mediated by NC. These findings 
strongly support a model in which multimerization-dependent Gag localization to 
uropods represents one mechanism by which the VS is formed. 
 
Results 
Gag localizes to uropods in polarized T cells.   
To examine Gag localization in polarized T cells, a YFP-tagged Gag (Gag-YFP) 
was expressed in either primary T cells or in a polarized T cell line, P2. To express Gag-
YFP, T cells were infected with VSV-G-pseudotyped HIV-1 that encodes Gag-YFP. Two 
days post-infection, cells were immunostained for uropod markers PSGL-1 or CD43 
(Figure 2.1A and B). Alternatively, the MTOC, which localizes to the base of the uropod, 
was detected using anti--tubulin (Figure 2.1C). In both primary CD4+ T cells and P2 
cells, approximately 50-60% of cells showed polarized morphology, and infection with 
VSV-G-pseudotyped HIV-1 did not substantially alter the percentage of polarized cells 
(Table 2.1). Primary CD4
+
 T cells expressing Gag-YFP showed strong colocalization of 
Gag on the plasma membrane with both uropod markers PSGL-1 and CD43, as well as 
co-polarization with the MTOC in virtually all Gag-positive cells with uropods (Figure 
2.1A-C and Table 2.2). In contrast, Gag-YFP showed segregation from LFA-1, a non-
uropod-associated protein [98] (Figure 2.1D). Similar to primary T cells, P2 cells also 
showed strong colocalization of PSGL-1 and Gag-YFP as well as co-polarization of the 
MTOC and Gag-YFP (Figure 2.1E and F and Table 2.2). In these cells, plasma-
membrane-associated Gag-YFP was highly polarized and detected only in the uropod 
region (Fig. 2.7C). Similarly, untagged Gag detected at the plasma membrane using anti-
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Gag antibodies also showed strong colocalization with uropod markers (supplementary 
Figure 2.S1). These results indicate that Gag localizes to uropods in polarized T cells. To 
determine whether uropod localization of Gag-YFP is stable, live cell analysis of primary 
T cells expressing Gag-YFP was performed. It was observed that Gag-YFP maintains 
localization in the uropod during T cell migration for a minimum of almost 30 min 
(Figure 2.1G, Supplementary Movie S1). 
To determine whether uropod-associated Gag is able to form mature particles, P2 
and primary CD4
+
 T cells were infected with VSV-G-pseudotyped HIV-1 encoding Gag-
iYFP. This Gag derivative contains YFP inserted between MA and CA and forms mature 
Gag proteins and free YFP upon cleavage by viral protease [99]. When cells expressing 
Gag-iYFP were immunostained with an anti-p17MA antibody, which only recognizes the 
mature, cleaved matrix domain of Gag [100, 101], the YFP signal was observed to 
colocalize substantially with p17MA signal at the uropod (Figure 2.2A and Table 2.3). It 
was also observed that both Gag-iYFP and Gag-YFP colocalize well with HIV-1 Env in 
the uropod (Figure 2.2B and Table 2.3). These results suggest that at least a subset of Gag 
localized at uropods is capable of forming Env-containing virus particles that undergo 
Gag processing essential for virion maturation. It should be noted that Env 
immunostaining was performed prior to fixation similar to previous studies [61,96]. Thus, 
the possibility of crosslinking playing a role in Env localization should be considered. 
 
Uropods mediate contact between infected and target T cells.   
Uropods in uninfected T cells have been shown to mediate contact between T 
cells and other cells [63, 65]. Therefore, accumulation of Gag in, and particle formation 
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at, the uropod may facilitate cell-to-cell transmission of HIV-1. To examine whether 
contact of HIV-1-infected T cells with target T cells is preferentially mediated by 
uropods, live cell imaging experiments were performed. Fresh target primary T cells were 
stained with a blue fluorescent dye, CMAC, and cocultured with Gag-YFP expressing 
primary T cells. This coculture was then immunostained with anti-PSGL-1, which had 
been prelabeled with Zenon AlexaFluor594. We observed that the uropod containing 
Gag-YFP maintained contact with CMAC-stained T cells for over 20 min as the cells 
moved through the field (Figure 2.3A, Supplementary Movie S2). These observations 
suggest that HIV-1-infected T cells are able to mediate stable contacts with target cells 
through their uropods. Newly formed contacts between Gag-YFP-expressing primary T 
cells and CMAC-stained target primary T cells formed during a 3-h coculture period 
were then quantified. An example of T cell contacts is shown in Figure 2.3B. We found 
that the majority of newly formed contacts occur at the uropod (Figure 2.3C), despite the 
average uropod constituting only approximately 20-30% of the total cell surface (data not 
shown). These results indicate that Gag-containing uropods stably and preferentially form 
new contacts with uninfected T cells. In these experiments, when target cells are also 
polarized, infected cell uropods formed a similar number of contacts with both ends of 
target cells (data not shown). 
 
Gag-containing uropods of infected cells participate in formation of the VS at which 
CD4 of target T cells accumulates.  
It is possible that cell contacts formed by infected cell uropods observed above 
actively participate in VS formation. To address this possibility, localization of CD4, 
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which is known to accumulate to the VS on the cell surface of target cells, was examined. 
P2 cells infected with VSV-G-pseudotyped HIV-1 expressing Gag-CFP and Env were 
immunostained for CD43 and mixed with target cells prelabeled with non-blocking, 
FITC-conjugated anti-CD4. After 3 h of coculture, cells were analyzed by live cell 
microscopy. When infected P2 cells were in contact with target SupT1 cells, CD4 on the 
surface of SupT1 cells accumulated to junctions formed between Gag-CFP-positive, 
CD43-positive uropods and target cells (Figure 2.4A). During quantitative analyses it was 
found that CD4 accumulation at cell-cell junctions predominantly takes place when Gag-
CFP-positive uropods, but not non-uropod regions, of infected P2 cells contact target 
SupT1 cells (Figure 2.4C). Such CD4 accumulation was rarely observed at junctions 
formed between Gag-CFP-negative or uninfected P2 cells and SupT1 cells (Figure 2.4A-
C). These results suggest that infected T cell uropods are actively involved in recruitment 
of CD4 to cell junctions, perhaps through accumulation of Env (Figure 2.2). As cell 
junctions enriched in viral antigens such as Gag and the HIV receptor CD4 are defined as 
the VS in previous studies [61], these results support a model in which uropods or 
uropod-derived membrane components specifically participate in formation of the VS. 
 
Myosin light chain kinase inhibitor depolarizes cell morphology and Gag 
localization and reduces cell-to-cell transfer of Gag-YFP.  
In order to explore whether Gag accumulation to uropods facilitates transmission 
of HIV-1, a cell-to-cell virus transfer assay was performed. In this flow-cytometry-based 
assay, the transfer of YFP fluorescence, representing virions, from infected P2 cells 
expressing Gag-YFP to CMTMR-stained SupT1 target cells was measured. Similar 
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assays have been used in previous studies for analyzing cell-to-cell virus spread [53, 71, 
102-104]. Representative flow cytometry plots for control cocultures are shown in Figure 
2.5A. Binding of cell-free virions to target cells was undetectable, which is consistent 
with previous studies [53] (data not shown). Therefore, transfer of fluorescence 
represents cell-to-cell virus transfer. Consistent with previous reports [53], we observed a 
significant decrease in virus transfer when cells were cocultured in the presence of an 
anti-CD4 antibody (Leu3A) that prevents CD4-Env interaction, but not an isotype control 
IgG (Figure 2.5A and C). These data confirm the importance of Env in cell-to-cell 
transfer of HIV-1. Using this assay, the effects of cell depolarization on cell-to-cell HIV-
1 transfer were examined using a myosin light chain kinase inhibitor, ML7. As expected, 
treatment of Gag-YFP-expressing P2 cells with this inhibitor disrupted uropod formation 
and dispersed Gag-YFP on the plasma membrane (Figure 2.5B). ML7 did not have a 
major impact on efficiency of VLP release by Gag-YFP calculated as the amount of 
virion-associated Gag as a fraction of total Gag (supplementary Figure 2.S2 and 
supplementary text). However, because ML7 treatment reduces protein synthesis (data 
not shown), it was possible that any decrease in cell-to-cell virus transfer by treatment 
with ML7 may have arisen from reduced Gag expression instead of disruption of cell 
polarity. To rule out the indirect effect of protein synthesis inhibition on virus transfer, 
we included 10 g/ml cycloheximide in all coculture conditions, including those treated 
with Leu3A and control IgG described above. As shown in Figure 2.5A, substantial virus 
transfer occurred even in the presence of cycloheximide. Finally, it was observed that in 
the presence of cycloheximide, ML7 treatment significantly decreased cell-to-cell virus 
transfer (Figure 2.5C and supplementary Figure 2.S3). Together with the data showing 
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that the uropod participates in formation of the VS (Figure 2.4), these results suggest that 
polarized localization of Gag and/or assembling particles at the uropod contributes to 
cell-to-cell transfer of virus particles to target cells.  
 
Gag localizes to uropod-specific microdomains.  
The results presented thus far suggest that Gag-laden uropods play a major role in 
cell-to-cell virus transmission. Thus, it is important to elucidate the mechanism by which 
Gag accumulates to uropods. Gag has been shown previously to associate with 
microdomains, such as lipid rafts and tetraspanin-enriched microdomains (TEMs) [10, 
54, 61, 105-112], and these microdomains are observed at the VS [61, 80, 113, 114]. 
Since subsets of these microdomains are implicated in polarized localization of proteins 
in leukocytes [49, 60, 115-118], it is conceivable that Gag utilizes uropod-specific 
microdomains for transport to the uropod. In this case, it would be expected to observe 
copartitioning of Gag and uropod markers to the same microdomain even in unpolarized 
cells. A common method to test whether two proteins share a propensity for associating 
with the same microdomain is to test for colocalization, or “copatching”, after 
crosslinking with antibodies specific to each of the two proteins [119-124]. This assay 
was used to examine whether Gag-YFP associates with uropod-directed microdomains in 
unpolarized P2 cells. As Gag forms multimers on its own, antibody-mediated 
crosslinking was needed only for cell surface marker proteins that include the uropod 
markers PSGL-1 and CD43 and the non-uropod marker LFA-1. Because Gag has been 
previously shown to colocalize with TEMs using similar methods [109], we also included 
the tetraspanin CD81 in the analysis. As observed in previous reports [109], we found 
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that Gag-YFP copatches with CD81 (Figure 2.6A) [correlation coefficient (CC)=0.46 
(see methods); Figure 2.6E]. Relative to CD81, however, the uropod markers PSGL-1 
and CD43 copatched more extensively with Gag-YFP (CC=0.69 and 0.70, respectively; 
Figure 2.6E). On the other hand, even though LFA-1 showed punctate localization as 
well, we observed a segregation of LFA-1 and Gag-YFP (Figure 2.6D) as indicated by 
the negative correlation coefficient (CC=-0.14; Figure 2.6E). Because copatching 
between Gag-YFP and uropod markers was observed even in non-polarized cells (Figure 
2.6B and C), these results suggest that Gag localizes to uropod-specific microdomains 
prior to, and perhaps during, T cell polarization.  
 To examine whether Gag-YFP localized at uropods had originated from the Gag-
YFP-positive patches observed in morphologically unpolarized cells, live-cell 
microscopy was performed of Gag-YFP-expressing P2 cells that were first depolarized 
by low temperature treatment prior to image recording at 37ºC. In these experiments, 
Gag-containing patches were observed to maintain colocalization with PSGL-1 and 
laterally move on the plasma membrane to the forming uropod as cells re-polarized. 
(Figure 2.6F, Supplementary Movie S3). Lateral movement of Gag-YFP was also 
observed in cells that were not immunostained for any marker, indicating that the 
observed movement was not caused by antibody-mediated crosslinking (supplemental 
Movie S4). These observations support a model in which Gag associates with uropod-
specific microdomains while establishing localization at the rear end of polarized T cells. 
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Env is not required for Gag localization to the uropod.   
It has been shown that Gag and Env interact with each other [125-131]. 
Furthermore, it has been shown that Env is required for the formation of virological 
synapses between infected and uninfected T cells [53, 61, 67, 68, 78, 80, 89], unlike those 
formed between uninfected T cells and infected macrophages [75]. Therefore, Env may 
play an active role in Gag localization to uropods. To address this possibility, we 
examined T cells expressing an HIV-1 molecular clone that encodes Gag-YFP but not 
Env (KFS/Gag-YFP). In these cells, KFS/Gag-YFP co-localized strongly with PSGL-1 
and copolarized with the MTOC at the uropod (Figure 2.7A), just as observed in cells 
expressing both Gag-YFP and Env (Figure 2.1). To examine microdomain partitioning, 
we also performed copatching assays for KFS/Gag-YFP and uropod markers in 
unpolarized cells. KFS/Gag-YFP was found to copatch with the uropod markers PSGL-1 
and CD43 (Figure 2.7B) at comparable levels to wild type (data not shown). Gag 
polarization indices was also compared between cells expressing Gag-YFP in the 
presence (Gag-YFP) or absence (KFS/Gag-YFP) of Env. The Gag polarization index 
describes the extent of Gag distribution along the plasma membrane from one cell pole to 
the other (see Materials and Methods). A lower index represents stronger polarization. 
The polarization index for KFS/Gag-YFP was nearly identical to that for Gag-YFP 
(Figure 2.7C, p=0.28). It was also found that the absence of Env had no impact on the 
preference for uropod-mediated contact between Gag-YFP-expressing primary T cells 
and CMAC-stained target primary T cells (Figure 2.7D, p=0.23). This finding suggests 
that Env may not be required for initial contact formation, even while it is required for 
transfer of virus particles (Figure 2.5) [53, 132] and maintenance of cell-cell conjugates 
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[53, 68, 78, 80]. Taken together, these results indicate that HIV-1 Env is dispensable for 
localization of Gag to the uropod.  
 
MA and CA are not required for Gag localization to the uropod.  
To identify the molecular determinants of Gag that facilitate its localization to the 
uropod, a panel of Gag mutants was examined for uropod localization (Figure 2.8). 
Because MA is essential for specific targeting of Gag to the plasma membrane [11, 12, 
100, 133-139], it is conceivable that MA also regulates specific localization of Gag to 
uropods. To test this possibility, the effect of MA deletion on Gag localization to uropods 
was examined. As MA is also essential for general membrane binding, to restore Gag 
membrane binding of the MA deletion mutant, a heterologous membrane binding 
sequence, an N-terminal 10-amino-acid sequence of Fyn kinase [Fyn(10)] was added to 
the N terminus of Gag. This sequence contains acylation signals for one myristoyl and 
two palmitoyl groups, and fully restores Gag membrane binding in the absence of the 
entire MA sequence [11]. Notably, the Fyn(10) sequence by itself is not capable of 
targeting proteins to uropods. As shown in Figure 2.9A, CFP attached to the Fyn(10) 
sequence [Fyn(10)-CFP] localized around the entire plasma membrane. In contrast, 
Fyn(10)/Gag-YFP localized to the uropod in the same cell (Figure 2.9A). These results 
indicate that the addition of Fyn(10) did not alter uropod localization of full-length Gag 
[Fyn(10)/Gag-YFP] in T cells, and that some region in Gag is required for its uropod 
localization. Notably, it was observed that Fyn(10)/MA/Gag-YFP, in which the entire 
MA sequence is deleted, still localized to the uropod efficiently in T cells (Figure 2.9B). 
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Taken together, these results indicate that Gag localization to the uropod requires 
sequences downstream of MA and not the MA sequence itself. 
The downstream sequence of MA includes the CA and NC domains. During virus 
particle formation, these domains are known to promote the dimerization and 
multimerization of Gag. To examine the roles played by Gag-Gag interactions in uropod 
localization, Gag derivatives with changes in either CA or NC was examined for uropod 
localization. Because Gag multimerization defects also reduce steady-state membrane 
binding [28, 42, 140], the Fyn(10) sequence was added to the CA and NC mutants. First, 
the plasma membrane localization of two YFP- and CFP-tagged CA mutants: an amino 
acid substitution mutant WM184,185AA (Fyn(10)/WMAA/Gag-YFP/-CFP) and a 
deletion mutant lacking the C-terminal domain (Fyn(10)/delCA-CTD/Gag-YFP/-CFP) 
was examined. Previously, it was observed by FRET microscopy that these CA mutants 
are deficient in Gag-Gag interactions in HeLa cells [28]. P2 cells were coinfected with 
VSV-G-pseudotyped viruses encoding derivatives of Gag-YFP or Gag-CFP, and their 
localization and multimerization were examined by fluorescence and FRET microscopy, 
respectively. WT Gag-YFP/-CFP and Fyn(10)/Gag-YFP/-CFP showed high FRET in the 
uropod, indicating that Gag multimers localize to uropods (Figure 2.10A and B). Notably, 
both Fyn(10)/delCA-CTD/Gag-YFP/-CFP and Fyn(10)/WMAA/Gag-YFP/-CFP also 
showed clear localization to the uropod (Figure 2.10C and D) although, as expected, 
these Gag mutants displayed low FRET (Figure 2.10C and D). The polarization index for 
Fyn(10)/WMAA/Gag-YFP was also nearly identical to that of Fyn(10)/Gag-YFP (Figure 
2.10E). Taken together, these results demonstrate that CA-mediated dimerization is not 
required for localization of Gag to the uropod.  
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NC is essential for localization of Gag to the uropod.  
To examine the role of NC in Gag localization to uropods, we next analyzed a 
mutant Gag that lacks most of the NC sequence (Fyn(10)/delNC/Gag-YFP/-CFP). In 
contrast to the MA and CA mutants that localized to the uropod, Fyn(10)/delNC/Gag-
YFP/-CFP localized over the entire plasma membrane (Figure 2.11A). An NC mutant in 
which 15 NC basic residues essential for RNA binding were substituted with alanine or 
glycine (Fyn(10)/14A1G/Gag-YFP/-CFP) also showed non-polarized localization  
(Figure 2.11B). These results indicate that NC is required for Gag localization to the 
uropod. Pleitropic impacts of NC mutations on Gag assembly precluded obtaining 
interpretable results regarding the effects of these mutations on cell-to-cell transfer 
(supplementary Figure 2.S2 and supplementary text). 
 
NC-mediated multimerization is required for Gag localization to the uropod.  
As confirmed by FRET microscopy (Figure 2.11A and B), both 
Fyn(10)/delNC/Gag-YFP/-CFP and Fyn(10)/14A1G/Gag-YFP/-CFP that are defective in 
polarized localization are also defective in Gag-Gag interaction. Therefore, it is possible 
that NC-mediated Gag multimerization or clustering plays a key role in Gag localization 
to the uropod. Alternatively, other functions of NC may facilitate Gag localization to the 
uropod. To distinguish between these possibilities, a Gag derivative in which NC was 
replaced by a leucine zipper sequence (LZ) derived from GCN4 (LZ/Gag-YFP/-CFP) 
was examined for uropod localization. Gag derivatives in which NC is replaced with this 
LZ sequence, which has no homology to NC, have been shown previously to multimerize 
efficiently [141-143]. We observed that LZ/Gag-YFP/-CFP localized to the uropod in a 
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majority of cells expressing this Gag derivative and yielded a WT level of FRET 
(compare Figure 2.11C with Figure 2.10A). Quantitative analysis of polarization 
indicated that LZ/Gag-YFP was not as efficiently polarized as WT, but nonetheless 
significantly more polarized than the NC point mutant Fyn(10)/14A1G/Gag-YFP (Figure 
2.11D). These results suggest that NC promotes Gag localization to the uropod through 
its ability to facilitate higher-order Gag multimerization. As the LZ sequence used above 
is a dimerization sequence, it would drive higher-order multimerization only in the 
presence of an additional dimerization motif such as CA-CTD. Thus, it was hypothesized 
that although Fyn(10)/delCA-CTD/Gag-YFP/-CFP and Fyn(10)/WMAA/Gag-YFP/-CFP 
localize to uropods (Figure 2.10C and D), in these contexts, LZ in the place of NC would 
be unable to promote Gag localization to uropods (Figure 2.11E and F). Indeed, cells 
expressing these constructs, Fyn(10)/WMAA/LZ/Gag-YFP and Fyn(10)/delCA-
CTD/LZ/Gag-YFP, showed localization of Gag over the entire plasma membrane, a 
pattern identical to that of the NC mutants (compare Figure 2.11E and F with A and B). 
Taken together, these results demonstrate that dimerization mediated by either CA-CTD 
or LZ alone is insufficient for localization to the uropod. However, NC-mediated higher-
order multimerization or clustering of Gag, defined as any multimer higher than a dimer 
and which likely occurs even in the absence of the CA-CTD dimerization interface, is 
essential for localization to the uropod.  
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Discussion 
In lymphoid organs, where HIV-1 likely spreads efficiently from infected to 
uninfected T cells, T cells adopt a polarized morphology and are highly motile. Thus, 
studying HIV-1 replication in polarized T cells may help to better understand how the 
virus spreads in vivo. In this study, it was found that HIV-1 Gag accumulates to, and 
forms mature virions at, the uropod in polarized T cells (Figures 2.1 and 2.2). These 
observations led to the question of whether uropod localization of HIV-1 Gag plays a role 
in the spread of the virus. In uninfected T cells, uropods are enriched in adhesion 
molecules and known to mediate contact with other cells [49]. Therefore, polarized virus 
assembly at uropods could facilitate cell-to-cell transmission of HIV-1. Consistent with 
this possibility, live cell microscopy and quantitative cell-cell contact analyses showed 
that HIV-1-infected cells contact target cells preferentially through their uropods (Figure 
2.3). Furthermore, a substantial majority of Gag- and CD4-positive cell-cell contacts, 
which define the VS [61], were observed where uropod-derived (CD43-positive), but not 
non-uropod (CD43-negative), regions of infected cells mediated contact with target cells 
(Figure 2.4). Consistent with these microscopy data, it was observed that ML7, a drug 
that blocks the polarization of T cells and formation of uropods, both dispersed Gag over 
the cell surface and reduced cell-to-cell transfer of virus particles significantly (Figure 
2.5). It should be noted that ML7 may also inhibit some myosin/actin processes besides 
cell polarization that may affect cell-to-cell virus transfer. Taken together, these results 
indicate that uropods of polarized T cells play an important role in cell-to-cell transfer of 
HIV-1. Notably, bone marrow hematopoietic stem cells have been shown to mediate not 
only contacts with osteoblasts, but also cell-to-cell transfer of plasma-membrane-
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associated molecules via their uropods [144]. This process, postulated to mediate 
intercellular signal transfer, may be a common cell-cell communication mechanism 
shared among cells of the hematopoietic cell lineage, including T cells. Thus, localization 
of HIV-1 components to, and subsequent virus assembly at, the uropod may represent yet 
another example in which viruses hijack cellular processes to facilitate its own 
replication. 
It has been reported by several groups that cell-to-cell HIV-1 transmission occurs 
via the VS. However, the steps leading to formation of the VS are not well defined. 
Observations described in this study suggest that at least one path toward establishment 
of the VS is the accumulation of viral components and assembling virions to the uropod. 
Uropods could then serve as a pre-formed platform that constitutes a VS upon cell-cell 
contact (Figure 2.12A). Consistent with this possibility, previous studies showed that 
disruption of the cytoskeleton, which also impairs cell polarity, reduces Gag 
accumulation to contact sites between infected and uninfected T cells [77, 78, 80, 145]. It 
is conceivable that suppression of uropod formation or inhibition of Gag localization to 
uropods may account for the observed reduction of VS formation upon cytoskeleton 
disruption.   
It is important to note that these observations do not preclude other modes of VS 
formation. For example, if morphologically unpolarized cells with dispersed Gag make 
contact with a target cell, Gag could re-localize laterally to the contact site. Consistent 
with such Gag movement, a recent imaging study showed that most cell conjugate 
formation precedes Gag redistribution when apparently unpolarized Jurkat cells were 
used as donor cells [67]. Such lateral movement could also occur in polarized cells that 
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initially contact target cells through a non-uropod region of the cell (Figure 2.12B). 
Movement of Gag-containing patches to contact sites has been observed in recent VS 
studies [67, 80]. It is possible that these patches may have originated at the uropod, 
although this point remains to be determined by long-term live cell monitoring of 
polarized T cells. Thus, in either mode of VS formation, prior formation of a platform 
enriched in Gag and other viral components, which take place at the uropod, may be an 
important first step in cell-to-cell virus transfer.  
 Polarized localization of Gag to the uropod appears to play an important role in 
HIV-1 spread. Thus, determining the mechanism of uropod localization of Gag is 
important. Previous studies have shown that some cell-surface proteins localize to the 
uropod upon antibody crosslinking through an undefined mechanism [146-148]. As 
dimerization and multimerization can be considered to be a form of crosslinking, it was 
examined whether Gag localization to uropods similarly depends on Gag 
multimerization. While CA dimerization mutations did not alter localization of Gag to the 
uropod (Figure 2.10), mutations that disrupt higher-order multimerization mediated by 
NC-RNA interactions did (Figure 2.11). Mutations in NC caused Gag to localize over the 
entire plasma membrane despite the presence of the CA dimerization interface. 
Furthermore, a heterologous dimerization sequence, LZ, restored the uropod localization 
of NC-deleted Gag. Finally, this LZ-dependent localization required the intact CA 
dimerization interface, supporting the importance of higher-order Gag multimerization. 
Therefore, although both CA dimerization and NC-RNA interaction are important for 
Gag assembly, it is the NC-dependent higher-order multimerization that is essential for 
Gag localization to the uropod. In this regard, uropod localization of Gag may be driven 
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by a mechanism similar to the one targeting multimerizing proteins to endosome-like 
domains reported recently to exist on the plasma membrane [149]. The nature of the NC-
dependent higher-order multimer directed to uropods remains to be elucidated; however, 
as CA dimerization mutants that did not yield substantial FRET signals still localized to 
uropods (Figure 2.10), it is likely that the uropod targeting process does not require the 
NC-dependent multimer to be in a highly aligned and packed form. As NC by itself can 
bind RNA in the absence of CA [150], it is conceivable that Gag clustering through 
binding to the same RNA molecule is sufficient for localization to uropods. 
Protein-protein interactions, which include clustering or multimerization of 
membrane proteins, are known to stabilize the microdomains with which those proteins 
associate [151]. In this study, it was observed that Gag copatches moderately with CD81 
and strongly with uropod markers PSGL-1 and CD43 even in non-polarized cells (Figure 
2.6). Using live cell analysis, it was also observed that Gag/PSGL-1 patches move 
laterally on the cell surface of unpolarized cells and accumulate at the forming uropod as 
cells polarize. These results support a model in which Gag, a multimerizing protein, 
associates with uropod-specific microdomains that carry Gag to the uropod. However, the 
mechanism by which these microdomains localize to the uropod remains unclear. It is 
important to note that not all types of microdomain are destined for the uropod. GM3-
containing lipid rafts have been shown to localize to the leading edge [60, 118, 152]. 
Therefore it is likely that there are complex sorting mechanisms by which specific 
subsets of microdomains are moved to the uropod. In this regard, it is of note that 
although LFA-1 behaves as a leading edge/non-uropod marker in T cells in suspension 
[153] (this study), this adhesion molecule redistributes to mid-cell and uropod regions 
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upon contact with ICAM-1-containing surfaces [154, 155]. Therefore, LFA-1 in infected 
cells may still modulate uropod-mediated T-cell-T-cell contacts upon encountering 
ICAM-1-bearing target cells, which would be in agreement with previous studies [96, 
103].  
While live cell analyses showed that patches of Gag laterally move to the uropod 
as cells re-polarize, they do not rule out the possibility that in an already polarized cell, de 
novo assembly of viruses preferentially occurs at the uropod or the cell contact without 
the lateral movement of Gag clusters. A recent study showed that MLV, another 
retrovirus, preferentially forms particles at contact sites in HEK293 cells [88]. This 
observation indicates that the site of retrovirus assembly can be polarized upon cell-cell 
contact formation in otherwise unpolarized cells. Notably, the polarized budding of MLV 
in HEK293 cells was found to be dependent on the MLV Env cytoplasmic tail. Similarly, 
the cytoplasmic tail of HIV-1 Env was reported to be important for polarized HIV-1 Gag 
localization in Jurkat T cells that appeared morphologically unpolarized [156]. In 
contrast, in this chapter, it was found that in the absence of Env or cell-cell contact, Gag-
YFP remained efficiently localized to the uropod in polarized T cells, including P2 and 
primary CD4
+
 T cells (Figures 2.1G and 2.7; data not shown). Therefore, it is possible 
that in T cells with a high propensity to establish front-rear polarity, Gag may not require 
Env or cell-cell contact to achieve polarized assembly. Further studies will determine the 
molecular mechanisms by which assembly sites for retroviruses are polarized in different 
cell types.  
Although Env was dispensable for Gag localization to the uropod, formation of 
stable cell conjugates as well as virus transfer have been shown to require Env-receptor 
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interaction [53, 67, 68, 78, 80, 132]. Consistent with these findings, an anti-CD4 blocking 
antibody (Leu3A) diminished cell-to-cell virus transfer (Figure 2.5) and prelabeling 
infected P2 cells with an anti-Env antibody (b12) reduced formation of cell conjugates 
with SupT1 cells (data not shown). Therefore, while uropods are enriched in adhesion 
molecules and form contacts with other cells frequently [49] regardless of the presence of 
Env, the Env-CD4 interaction is likely to stabilize such contacts during formation of the 
VS.  
In summary, this chapter elucidates a series of molecular events leading to the 
formation of a VS. The observations made have led to the formation of a working model 
(Figure 2.12) in which higher-order multimerization, or clustering, mediated by NC is 
required for Gag association with uropod-specific microdomains. This microdomain 
association then facilitates localization of the assembling virus to the uropod. According 
to this model, the uropod, laden with HIV-1 components and particles, then serves as a 
pre-formed platform that mediates contact with target cells (Figure 2.12A) or 
redistributes to contacts formed elsewhere (Figure 2.12B). Such contacts could then 
constitute a VS, which likely facilitates cell-to-cell virus transfer of HIV-1. 
 
 63 
Materials and Methods 
Plasmids 
The HIV-1 molecular clone pNL4-3 [157] and its derivatives encoding Gag-YFP 
and Gag-CFP fusion proteins (pNL4-3/Gag-YFP/-CFP) [11, 28] were described 
previously. The latter two constructs contain an extensive deletion of pol and silent 
mutations to reduce ribosomal frameshift to the pol reading frame and does not express 
Vif or Vpr. For YFP and CFP, monomeric Venus [158, 159] and monomeric Cerulean 
[160] variants were used, respectively. pNL4-3/WM184,185AA/Gag-YFP/-CFP 
(renamed as pNL4-3/WMAA/Gag-YFP/-CFP), pNL4-3/delCA-CTD/Gag-YFP/-CFP, 
pNL4-3/14A1G/Gag-YFP/-CFP, pNL4-3/delNC/Gag-YFP/-CFP and the Fyn(10)-
modified versions of those plasmids were previously described [28]. In this study, pNL4-
3/Fyn(10)fullMA/GagVenus described previously [11, 28] was renamed as pNL4-
3/Fyn(10)/Gag-YFP for simplicity. pNL4-3/Fyn(10)/MA/Gag-YFP was previously 
described [11]. pNL4-3/KFS/Gag-YFP was generated by cloning the XhoI-SalI fragment 
of pNL4-3-KFS (a kind gift from Dr. Eric Freed [161]) into pNL4-3/Gag-YFP. To 
construct pNL4-3/LZ/Gag-YFP/-CFP, the sequence encoding GCN4 leucine zipper in the 
ZWT plasmid, a kind gift from Dr. Heinrich Gottlinger [142], was cloned into pNL4-
3/Gag-YFP/-CFP using standard molecular cloning techniques. The double mutants 
pNL4-3/Fyn(10)/WMAA/LZ/Gag-YFP/-CFP and pNL4-3/Fyn(10)/delCA-CTD/LZ/Gag-
YFP/-CFP were generated by cloning a fragment containing the leucine zipper sequence 
from pNL4-3/LZ/Gag-YFP into pNL4-3/Fyn(10)/WMAA/Gag-YFP/-CFP and pNL4-
3/Fyn(10)/delCA-CTD/Gag-YFP/-CFP, respectively. pNL4-3/Gag-iGFP (a kind gift from 
Dr. Benjamin Chen [99])  was used to construct pNL4-3/Gag-iYFP.  
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Virus Stocks  
Stocks of HIV-1 mutants, pseudotyped with vesicular stomatitis virus G protein 
(VSV-G), were prepared by transfecting 5.6x10
5
 293T or HeLa cells with 1.5 g pNL4-3 
derivative encoding a Gag-YFP/-CFP fusion protein, 1.5 g pCMVNLGagPol-RRE 
[105], and 0.5 g pHCMV-G (a kind gift from Dr. J. Burns [162]). Two days post 
transfection, virus-containing supernatants were filtered through a 0.45 m filter and used 
for inoculation of T cells.  
 
Cells  
To prepare a polarized T cell line, T cell clones were obtained by limiting dilution 
of A3.01 T cells (AIDS Research and Reference Reagent Program). Typical A3.01 cell 
cultures naturally contain 10-20% of cells with a polarized morphology. After limiting 
dilution, T cell clones were examined for cell morphology and polarized PSGL-1 
localization. A cell clone, in which approximately 50-60% of cells were polarized, was 
designated “P2” and used for experiments. These cell lines, as well as the SupT1 cell line 
(AIDS Research and Reference Reagent Program), were cultured in RPMI containing 
10% fetal bovine serum (FBS)(RPMI-10%FBS). Primary T cells were isolated from 
buffy coats obtained from the New York Blood Center. The buffy coats were diluted in a 
1:1 ratio with phosphate buffered saline (PBS) containing 2% FBS (PBS-2%FBS), and 
peripheral blood mononuclear cells (PBMCs) were isolated using centrifugation through 
ficoll (GE Healthcare) according to the manufacturer’s instructions. Isolated PBMCs 
were then plated on polystyrene petri dishes for 2 h to separate the adherent monocytes 
and non-adherent lymphocytes. Lymphocytes were activated in RPMI-10%FBS 
 65 
containing phytohemagglutinin (PHA) (Sigma. St. Louis, MO) (6 g/ml) and IL-2 (20 
units/ml) (Roche. Basel, Switzerland) for 2-3 days. Primary CD4
+
 T cells were isolated 
with the MACS magnetic antibody bead kit (Miltenyi Biotec. Bergisch Gladbach, 
Germany) using anti-CD4 beads and MS columns. Cells were then cultured overnight in 
RPMI-10%FBS and IL-2 (20 units/ml) and used for experiments. IL-2 has been shown to 
induce a comparable level of T cell polarization and locomotion to those induced by 
chemokines such as RANTES and MIP-1 [163, 164]. 
 
Infection   
Cells were infected with virus stocks by spin infection; 3x10
5
 P2 cells or 5x10
5
 
primary T cells were resuspended in 200 µl virus stock with 4 µg/ml polybrene and 
centrifuged at 2500 rpm for 2 h at 15°C. Cells were cultured at 37°C in RPMI-10% FBS 
for 2-3 days (in the presence of 20 units/ml IL-2 for primary T cells).  
 
Copatching Assay  
Mouse anti-PSGL-1, CD43, CD81, or LFA-1 (all from BD Biosciences 
Pharmingen. San Diego, CA) were prelabeled with the secondary antibody (AlexaFluor-
594-conjugated goat anti-mouse IgG (Invitrogen. Carlsbad, California)) for 30 min. 
Infected cells were cultured in 200 l of RPMI-10%FBS containing this antibody mixture 
for 1 h at 37°C, after which they were washed with RPMI-10%FBS and fixed in 1ml 4% 
paraformaldehyde in PBS (PFA). After washing with PBS-2%FBS, cells resuspended in 
a small volume (~10 l) of the same buffer were mixed with equal volume of 
Fluoromount-G (SouthernBiotech. Birmingham, Alabama), and 3 l of this mixture was 
 66 
mounted on glass slides. Images were acquired with a Nikon TE-2000U inverted 
epifluorescence microscope. Z-series of images were acquired with 0.2 m intervals 
between focal planes. Maximum intensity projection images of the z-series images 
composed of 56 focal planes were obtained with ImageJ software (NIH; downloaded 
from http://rsbweb.nih.gov/ij/). Copatching quantification was performed using the 
correlation plot function of the Metamorph 6 software (Molecular Devices. Sunnydale, 
California). To identify punctate signals objectively and to remove background signals 
from copatching analyses, the background, calculated as the median intensity of a 32x32-
pixel region surrounding each pixel, was subtracted from the original image [165], point 
noise was removed using a 3x3 median filter [166], and the minimum threshold was set 
to twice the average fluorescence intensity of the cell of interest and applied to the 
images. These images were then used for calculation of Pearson’s correlation coefficients 
(CC), representing copatching. Person’s correlation coefficients between 0.5 and 1 
represent moderate to very strong correlation, between 0 to 0.5 represents low to 
moderate correlation with 0 representing random distribution, and below 0 represents 
segregation of the two signals.  
 
Immunostaining  
To avoid altering cell morphology, cell suspensions were placed in round-bottom 
tubes and left still at 37ºC in the presence of 5% CO2 for at least 1 h prior to fixation.  
Subsequently, most of the culture supernatant was removed carefully, and cells were 
fixed in 1ml 4% PFA for 20 minutes. Fixed cells were washed with PBS-2%FBS and 
then incubated for 1 h in PBS-2%FBS containing primary antibodies against cell surface 
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molecules (PSGL-1 and LFA-1) followed by washing with PBS-2%FBS. For 
experiments in which CD43 was used as a uropod marker, cells were first incubated with 
anti-CD43 for 30 min as done in previous studies [64]. Subsequently, cells were rinsed 
with RPMI-10%FBS twice, incubated with AlexaFluor 594-conjugated anti-mouse IgG 
for 30 min, rinsed with RPMI-10%FBS twice, and cultured for an additional 30 min at 
37ºC prior to fixation. Detection of Env on the cell surface was performed similarly, 
except that primary and secondary antibodies used were anti-gp120 (IgG1 b12; AIDS 
Research and Reference Reagent Program) and AlexaFluor-594-conjugated anti-human 
IgG (Invitrogen), respectively. For detection of -tubulin (to identify the MTOC) and 
mature p17MA, fixed cells were permeabilized by a 10-min incubation in PBS containing 
0.2% saponin (Fluka Biohemica. Buchs, Switzerland) and 5% FBS prior to incubation 
with primary antibodies, anti--tubulin (Sigma; clone B-5-1-2) and anti-p17MA (Applied 
Biotechnologies. Columbia, Maryland), respectively. Primary antibodies were detected 
by treating cells with AlexaFluor 594-conjugated goat anti-mouse IgG for 30 minutes. 
Cells were then washed again with PBS-2%FBS and mounted on glass slides, as 
described above, for microscopy. 
 
Live Cell Microscopy  
Cells were infected with VSV-G-pseudotyped HIV-1 encoding Gag-YFP. Two 
days post-infection, cells were immunostained with anti-PSGL1 prelabeled with the 
Zenon AlexaFluor 594 reagent (Invitrogen) according to manufacturer’s instruction or 
AlexaFluor 594-conjugated anti-mouse IgG as described for the copatching assay. To 
morphologically depolarize cells, 4-well chamber coverslips (Nunc. Rochester, NY), 
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containing Gag-YFP-expressing cells, were placed at 4°C for 30 min. To repolarize cells, 
the chamber coverslips were then transferred to a pre-warmed (37°C) microscope stage. 
Time-lapse images were acquired with an interval of 30 s for up to 1 h. The images were 
then converted to AVI files by ImageJ.  
 
Fluorescence Resonance Energy Transfer (FRET) Analysis  
Cells were co-infected with VSV-G-pseudotyped HIV-1 encoding YFP- and CFP-
tagged versions of each Gag mutant, cultured and fixed as described above. Cells were 
subsequently permeabilized, immunostained for -tubulin, and mounted as described 
above. Images were collected using four filter combinations: AlexaFluor 594 
excitation/AlexaFluor 594 emission, YFP excitation/YFP emission, CFP excitation/CFP 
emission, and CFP excitation/YFP emission. FRET was calculated using FRET 
stoichiometry as previously described [28, 167].  
 
Analysis of Cell-cell Contact and VS  
5x10
5
 primary CD4
+
 T cells were infected with VSV-G pseudotyped HIV-1 
encoding Gag-YFP or KFS/Gag-YFP. Two days post infection, 5x10
5
 fresh primary 
CD4
+
 T cells were stained with 1 M CMAC (Invitrogen) for 30 min. Infected T cells 
were then co-cultured with CMAC-stained target T cells for 3 h in a chamber coverslip at 
37°C. Images of 50-60 polarized and YFP-expressing cells were then acquired, and the 
number of contacts these cells formed with CMAC-labeled cells, which represent newly 
formed contacts, were quantified and categorized as uropod- or non-uropod-mediated 
contacts. For analysis of the VS, 2x10
5
 P2 cells were infected with VSV-G-pseudotyped 
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HIV-1 encoding Gag-CFP. Two days post-infection, cells were immunostained with anti-
CD43 and a minimal amount of AlexaFluor-594-conjugated anti-mouse IgG. After 
extensive washing, 1x10
5
 of these cells or the same number of uninfected P2 cells were 
mixed with 1x10
5
 target cells (SupT1 cells) that were prelabeled with non-blocking 
FITC-conjugated anti-CD4 (Clone L120, BD Biosciences. San Jose, California) and 
cocultured for 3 h in chamber coverslips at 37°C. These cocultures in the chamber 
coverslips were placed on a microscope stage set at 37ºC, and images were acquired 
using appropriate excitation and emission filters. 
 
Cell-to-Cell Virus Transfer Assay  
2x10
5
 P2 cells were infected with VSV-G-pseudotyped HIV-1 encoding Gag-
YFP. Two days post-infection, 5x10
5
 target SupT1 cells were stained with 1 M 
CellTracker CMTMR (Invitrogen. Carlsbad, California) for 15 min, washed with RPMI-
10%FBS, incubated for 2 h in RPMI-10%FBS, and washed again in RPMI-10%FBS. 
Infected donor and CMTMR-stained target cells were cocultured in 0.5 ml RPMI-
10%FBS for 3 h in the presence or absence of the myosin light chain kinase (MLCK) 
inhibitor, ML7 (40 M) (EMD Biosciences. San Diego, California), or the solvent 
negative control DMSO. The CD4 blocking antibody Leu3A (0.25 g/ml) (BD 
Biosciences) and isotype anti-mouse IgG control antibody (0.25 g/ml) (Santa Cruz 
Biotechnology. Santa Cruz, California) were utilized to validate the assay, as it was 
shown previously using a similar assay that virus transfer was dependent on Env-CD4 
interaction [53](Figure 2.4A). To rule out the possibility that inhibitors affect viral 
protein synthesis and thereby indirectly alter virus transfer, 10 g/ml cycloheximide, 
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which abolishes protein synthesis, was added at the beginning of coculture. After 3 h of 
coculture, cells were fixed in 4% PFA. Double-positive cells, which represent CMTMR-
positive target cells that received YFP-containing virus particles, were identified by flow 
cytometry (see Figure 2.4A for examples). Results were presented as a percentage of 
double-positive cells compared to total CMTMR-stained target cells.  
 
Quantification of Polarization  
To measure morphological polarization of T cells, outlines of Gag-YFP-
expressing P2 cells were determined by manually tracing the cell perimeter using the 
ImageJ program. Circularity values were then calculated based on this outline using the 
Measure function of ImageJ. The output values range between 0 and 1, with 1 
representing a perfect circle. This method has been described previously [168]. 
Morphologically polarized cells with circularity values below 0.8 were further examined 
for polarization of Gag localization. To quantify polarity of Gag localization, a 10-
segmented grid was placed over each cell along the cell’s longest axis. The number of 
segments that contained plasma-membrane-associated Gag was then used as the 
polarization index. Lower values correspond to more polarity of Gag on the cell surface. 
Examples of these quantifications are shown in supplementary Figure 2.S4. 
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Figure 2.1. Gag stably localizes to the uropod in polarized T cells.   
Primary T cells (A-D) and P2 cells (E-F) expressing Gag-YFP (green) were 
immunostained for uropod and non-uropod markers as described in the Materials and 
Methods section, and observed using an epifluorescence microscope. Uropods were 
identified by the presence of PSGL-1 (A and E) and CD43 (B) as well as by the location 
of the MTOC determined by immunostaining with anti--tubulin (C and F, arrows). 
LFA-1 (D) is a known non-uropod marker and served as a negative control. G) Cells 
expressing Gag-YFP (green) were immunostained with anti-PSGL-1 prelabeled by 
AlexaFluor-594-conjugated anti-mouse IgG (red). Images were acquired every 30 s for 
30 min as the polarized cell migrates through the field. Yellow color indicates 
colocalization of PSGL-1 and Gag-YFP.  
 
 
 
 
 
 
 
 
 
 
 
 
 
G 0min 2.5min 5min 7.5min
10min 12.5min 15min 17.5min. i1 in
20min 22.5min 25min 27.5min
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Table 2.1. Quantification of T cell Polarization. 
Primary CD4+ T cells and P2 cells infected with VSV-G-pseudotyped HIV-1 encoding 
Gag-YFP were cultured for two days, fixed, immunostained for cellular proteins, and 
examined by fluorescence microscopy.  Gag-YFP-positive and -negative cells were 
categorized based on cell morphology, and cells in each category were counted.  Cells 
with circularity below 0.8 (see Materials and Methods) were categorized as polarized 
cells. 
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Table 2.2. Copolarization of Gag with Cellular Markers. 
Primary CD4
+
 T cells and P2 cells infected with VSV-G-pseudotyped HIV-1 encoding 
Gag-YFP were cultured for two days, immunostained for cellular proteins, and examined 
by fluorescence microscopy (see Materials and Methods). Gag-YFP-positive cells that 
were categorized as polarized cells based on cell morphology were further examined for 
polarized localization of Gag-YFP and copolarization of Gag-YFP with cellular markers. 
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Figure 2.2. Mature Gag and Env localize to the uropod.  
Primary CD4
+
 T cells and P2 cells were infected with a VSV-G-pseudotyped HIV-1 
encoding Gag-iYFP (green) (A and B) or Gag-YFP (green) (C). A) For detection of 
mature Gag, cells were fixed, permeabilized, and immunostained with anti-p17MA (red) 
as described in Materials and Methods and observed with an epifluorescence microscope. 
B) and C) For detection of Env on the cell surface, infected cells were incubated with 
anti-gp120 (IgG1 b12) and subsequently with AlexaFluor-594-conjugated anti-human 
IgG prior to fixation as described in Materials and Methods.  
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Table 2.3. Colocalization of YFP-Tagged Gag with Antibody-Detected Viral 
Proteins 
Primary CD4+ T cells and P2 cells infected with VSV-G-pseudotyped HIV-1 encoding 
Gag-iYFP or Gag-YFP were cultured for two days, immunostained for viral proteins, and 
examined by fluorescence microscopy. YFP-positive polarized cells were examined for 
colocalization of the cell surface YFP-tagged Gag proteins and viral antigens detected 
by anti-p17MA or anti-gp120 (b12). 
 
 
 
 
 
 
 
 
 
 
 
 
 76 
 
Figure 2.3. Infected polarized T cells form contacts with target cells via their 
uropods.  
A) Primary T cells expressing Gag-YFP (green) were immunostained with an anti-PSGL-
1 antibody (red) as described in Figure 2.1G and cocultured with fresh primary T cells 
from the same donor stained with the fluorescent dye CMAC (blue). Regions of 
colocalization between Gag and PSGL-1 are shown in yellow. Live cell images were 
taken every 30 s for 20 min. A series of images with 5-min intervals is shown. Note that 
the uropod, enriched in Gag-YFP and PSGL-1, mediates stable contacts with target cells 
(*). B) Examples of uropod- and non-uropod-mediated contacts between a Gag-YFP 
expressing primary T cell (dotted white outline) with CMAC-labeled primary T cells are 
shown. C) Uropod-mediated and non-uropod-mediated contacts were counted for a total 
of 74 polarized Gag-YFP-positive cells contacting CMAC-labeled cells in two 
independent experiments. P values were determined using Student’s t test. *, P<0.05.  
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Figure 2.4. Gag-positive uropods form contacts enriched in CD4.  
A) P2 cells expressing Gag-CFP (cyan; pseudo-colored in blue in the merge panel) were 
immunostained with anti-CD43 and AlexaFluor-594-conjugated anti-mouse IgG (red). 
Subsequently, these cells were cocultured with SupT1 cells prelabeled with FITC-
conjugated anti-CD4 (green) for 3 h and examined by live cell microscopy. A target cell 
(center) in contact with both Gag-CFP-positive (left) and Gag-CFP-negative (right) cells 
is shown. B) Uninfected P2 cells were immunostained with anti-CD43 and co-cultured 
with SupT1 cells prelabeled for CD4 as done in (A). C) In experiments represented in 
panels A and B, junctions between target SupT1 cells and Gag-CFP-expressing, non-
Gag-CFP-expressing, or uninfected P2 cells were classified into uropod-mediated and 
non-uropod-mediated contacts based on the presence of CD43. The percentage of 
contacts with accumulation of CD4 relative to total contacts was determined for each 
category. Data from three independent experiments were shown as means +/-standard 
deviation. P values were determined using Student’s t test. ***, P<0.001; ****, 
P<0.0001. Numbers of contacts detected and examined for CD4 accumulation in each of 
these three experiments are: Gag-CFP-positive/CD43-positve contacts, 56, 56, 57 (total 
169); Gag-CFP-positive/CD43-negative contacts, 21,17,18 (total 56); Gag-CFP-
negative/CD43-positive contacts, 26, 35, 39 (total 100); Gag-CFP-negative/CD43-
negative contacts, 17, 24, 28 (total 69); uninfected/CD43-positve contacts, 56, 67, 86 
(total 209); and uninfected/CD43-negative contacts, 20, 38, 55 (total 113). 
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Figure 2.5. ML7 depolarizes cell morphology and Gag localization and reduces cell-
to-cell transfer of Gag-YFP.  
A) Transfer of Gag-YFP fluorescence from infected P2 cells to CMTMR-stained SupT1 
target cells during a 3-h coculture period was measured by flow cytometry. ML7, DMSO, 
or antibodies, along with 10 g/ml cycloheximide, were added at the beginning of the 
coculture period. Flow cytometry plots for CMTMR-labeled target cells co-cultured with 
uninfected cells as well as CMTMR-labeled target cells cocultured with Gag-YFP-
expressing infected cells in the presence or absence of IgG or Leu3A are shown. Gate A, 
CMTMR-labeled target cells; gate B, double positive cells representing target cells with 
transferred Gag-YFP particles; and gate C, YFP-expressing cells either fused or 
conjugated to CMTMR-labeled target cells. B) Images of cycloheximide-treated P2 cells 
expressing Gag-YFP were acquired after 3-h coculture with CMTMR-stained SupT1 
cells in the presence or absence of DMSO or ML7. Note that almost all the cells adopt 
round unpolarized morphology upon treatment with ML7 and that ML7-treated infected 
cells show dispersed Gag-YFP localization.  The latter point is clearer in the higher 
magnification image (bottom panel) of a region specified in the middle row.  Also note 
that the cell density of the cocultures in experiments shown in panel A (images shown in 
supplementary Figure 2.S3 and discussed in the supplementary text) is 10 fold higher 
than in panel B. C) Relative efficiencies of cell-to-cell virus transfer were calculated as 
the percentage of double positive cells out of the total CMTMR-labeled cells (Virus 
transfer efficiency=B/(A+B+C)*100; error bars represent standard deviation). P values 
were determined using Student’s t test. ***, P<0.001.   
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Figure 2.6. Gag associates with uropod-specific microdomains that carry Gag to the 
uropod.  
Unpolarized P2 cells expressing Gag-YFP (green) were examined for copatching with 
CD81 (A), CD43 (B), PSGL-1 (C), or LFA-1 (D). Cells were incubated with specific 
primary mouse monoclonal antibodies premixed with the fluorescent secondary antibody 
(red) followed by fixation. Z series of images of morphologically unpolarized cells were 
acquired and used to generate maximum projection images of each color using 
Metamorph 6 software. Merged images are shown in the right column of each panel.  
Several small copatching puncta are indicated by arrows. E) Quantification of 
copatching. Correlation coefficients between Gag-YFP and cell surface marker signals 
were calculated from a total of 18 cells for each marker. A value of 1 represents perfect 
colocalization, a value of -1 represents complete segregation, and a value of 0 represents 
a random distribution. P values were determined using Student’s t test. NS, not 
significant. **, P<0.01. ***, P<0.001. F) Time lapse images of a Gag-YFP-expressing T 
cell during repolarization. Gag-YFP(green)-expressing P2 cells were immunostained for 
PSGL-1 (red) as described for panels A-D. Cells were then depolarized by incubation at 
4°C for 30 min. Approximately 5 min after chamber coverslips containing depolarized 
cells were transferred to the microscope stage maintained at 37°C, acquisition of live cell 
images at indicated time points was begun. Note that the small patches (arrows) migrate 
and coalesce to the large patch (arrowheads) at the cell pole that eventually forms the 
uropod.  
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Figure 2.7. Env is not required for Gag localization to the uropod.  
A) P2 cells expressing KFS/Gag-YFP (green) were immunostained after fixation with 
anti-PSGL-1 (red, upper panel) or anti--tubulin (red, lower panel, arrow indicates 
MTOC) as described for Figure 2.1. B) KFS/Gag-YFP-expressing P2 cells were 
immunostained for PSGL-1 or CD43 (red) using the co-patching method as described for 
Figure 2.6, and Z-series of images of unpolarized cells were acquired. Maximum 
projections of each color were generated from the Z stacks and merged to examine 
colocalization (yellow). Several small copatching puncta are indicated by arrows. C) The 
Gag polarization index was determined as described in the Materials and Methods section 
for cells expressing Gag-YFP and KFS/Gag-YFP. Four separate experiments (32, 23, 39, 
and 37 cells each) for a total of 131 cells for Gag-YFP and 3 separate experiments (34, 
48, and 30 cells each) for a total of 112 cells for KFS/Gag-YFP were used for 
quantification of Gag polarization. P values were determined using Student’s t test. NS, 
not significant. D) Cell-cell contact assays were performed as in Figure 2.3. This graph 
compares the results of Figure 2.3 to the results obtained with cells expressing KFS/Gag-
YFP, which had been obtained concurrently. P values were determined using Student’s t 
test. *, P<0.05. 
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Figure 2.8. Gag derivatives used in this study and their localization pattern.  
HIV-1 molecular clones that express Gag-fluorescent protein fusions (WT Gag-YFP/-
CFP) were generated. Deletions or amino acid substitutions were created in the MA 
domain (Fyn(10)/MA/Gag-YFP/-CFP), CA domain (Fyn(10)/delCA-CTD/Gag-YFP/-
CFP and Fyn(10)/WMAA/Gag-YFP/-CFP) and the NC domain (Fyn(10)/delNC/Gag-
YFP/-CFP, Fyn(10)/14A1G/Gag-YFP/-CFP and LZ/Gag-YFP/-CFP). Gag derivatives 
containing LZ replacement of NC combined with the CA mutations were also used 
(Fyn(10)/delCA-CTD/LZ/Gag-YFP/-CFP and Fyn(10)/WMAA/LZ/Gag-YFP/-CFP). The 
Fyn(10) sequence, a single myristoylation and dual palmitoylation signal, was added to 
the N terminus of all Gag derivatives except WT Gag-CFP/-YFP and LZ/Gag-CFP/-YFP. 
Results as to whether these Gag derivatives localize specifically to the uropod (Y) or 
distribute over the entire cell surface (N) are summarized in the right column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
myr-
MA CA NC p6
Gag-CFP/-YFP
Fyn(10)/Gag-CFP/-YFP
FP
myr-
p
a
lm
-
p
a
lm
-
Fyn(10)/delCA-CTD/Gag-CFP/-YFP
Fyn(10)/WMAA/Gag-CFP/-YFP
Fyn(10)/14A1G/Gag-CFP/-YFP
myr-LZ/Gag-CFP/-YFP
Fyn(10)/WMAA/LZ/Gag-CFP/-YFP
Fyn(10)/delNC/Gag-CFP/-YFP
myr-
p
a
lm
-
p
a
lm
-
myr-
p
a
lm
-
p
a
lm
-
myr-
p
a
lm
-
p
a
lm
-
myr-
p
a
lm
-
p
a
lm
-
myr-
p
a
lm
-
p
a
lm
-
myr-
p
a
lm
-
p
a
lm
-
myr-
p
a
lm
-
p
a
lm
-
xx
xxx
xx
localize to
uropod?
Y
Y
Y
Y
Y
N
N
N
N
Y
Fyn(10)/delCA-CTD/LZ/Gag-CFP/-YFP
Fyn(10)/MA/Gag-CFP/-YFP
 82 
 
 
Figure 2.9. The MA sequence is not required for Gag localization to the uropod.  
A) P2 cells were co-transfected with plasmids that express Fyn(10)/Gag-YFP (green) and 
Fyn(10)-CFP (blue). Cells were then stained for -tubulin (red, arrow indicates MTOC). 
B) Cells expressing Fyn(10)/MA/Gag-YFP (green) were immunostained with anti--
tubulin (red, arrow indicates MTOC).  
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Figure 2.10. CA-mediated dimerization is not required for Gag localization to the 
uropod.  
A-D) P2 cells expressing Gag-YFP (green) and Gag-CFP (blue) or their derivatives were 
stained for -tubulin (red) to identify the MTOC. Multimerization efficiency of each Gag 
mutant was measured by FRET. A) WT Gag-YFP/-CFP, B) Fyn(10)/Gag-YFP/-CFP, C) 
Fyn(10)/delCA-CTD/Gag-YFP/-CFP, and D) Fyn(10)/WMAA/Gag-YFP/CFP. Note that 
Gag derivatives with CA changes both localize to the uropod but show low FRET. Color 
scale bar indicates colors associated with high (1) or low (0) FRET. E) Polarization 
indices were calculated for Fyn(10)/Gag-YFP and Fyn(10)/WMAA/Gag-YFP (see 
Materials and Methods). Three separate experiments (a total of 89 P2 cells for 
Fyn(10)/Gag-YFP and 78 P2 cells for Fyn(10)/WMAA/Gag-YFP) were used for 
quantification. Error bars represent standard deviation. P values were determined using 
Student’s t test. NS, not significant.  
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Figure 2.11. Higher-order multimerization mediated by NC is required for Gag 
localization to the uropod.  
A-C) P2 cells expressing Gag-YFP and Gag-CFP that contain an NC deletion or 
substitutions (green/blue) were immunostained with anti--tubulin (red, arrow indicates 
MTOC). Note that Fyn(10)/delNC/Gag-YFP/-CFP (A) and Fyn(10)/14A1G/Gag-YFP/-
CFP (B) localize over the entire plasma membrane. Both mutants show reduced levels of 
FRET. In contrast, LZ/Gag-YFP/-CFP (C) mostly localizes to the uropod. High FRET is 
observed indicating that multimerization is rescued as well. D) Polarization indices were 
calculated for LZ/Gag-YFP and Fyn(10)/14A1G/Gag-YFP and compared to WT Gag-
YFP. LZ/Gag-YFP is less efficient in polarization, but significantly more efficient than 
Fyn(10)/14A1G/Gag-YFP. A total of 131 cells for Gag-YFP, 79 cells for LZ/Gag-YFP, 
and 69 cells for Fyn(10)/14A1G/Gag-YFP from three separate experiments were 
measured for polarized localization of Gag. Error bars represent standard deviation. P 
values were determined using Student’s t test. *, P<0.05. ****, P<0.0001. E) and F) 
Double mutants containing the LZ sequence with the two different changes in the CA C-
terminal domain, Fyn(10)/WMAA/LZ/Gag-YFP/-CFP (E) and Fyn(10)/delCA-
CTD/LZ/Gag-YFP/-CFP (F), were expressed in P2 cells. Note that both Gag derivatives 
fail to localize to the uropod despite the presence of the LZ sequence. 
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Figure 2.12. Working Model.  
A) Based on the findings in this study, we have postulated a working model in which 
NC-mediated clustering of Gag allows association of Gag with uropod-specific 
microdomains that facilitate movement to the uropod in polarizing T cells. B) The virus-
laden uropod, acting as a pre-formed platform that may either mediate contact with target 
cells (a) or relocalize to contacts formed elsewhere subsequently (b), constitutes a VS that 
facilitates cell-to-cell transmission of HIV-1.  
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Figure 2.S1. Untagged Gag detected at the plasma membrane using anti-Gag 
antibodies shows strong colocalization with uropod markers.  
P2 cells infected with wild type HIV-1 (NL4-3) were labeled with anti-PSGL-1 or anti-
CD43 (red) prior to fixation. Fixed cells were permeabilized and immunostained with 
anti-p17MA or anti-p24CA (green). Note that when Gag is detected on the cell surface, it 
colocalized with uropod markers. 
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Figure 2.S2. Effects of ML7 on VLP release efficiency  
P2 cells expressing Gag-YFP or Fyn(10)delNC Gag-YFP were metabolically labeled 
with [
35
S] methionine/cysteine for 2 h in the presence of 40 µM ML7 (+) or DMSO (-). 
Cell and virus lysates were subjected to immunoprecipitation of viral proteins using HIV-
Ig. Virus release efficiency was calculated as the amount of virion-associated Gag as a 
fraction of total (cell plus virion) Gag synthesized during a 2-h metabolic labeling period. 
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Figure 2.S3. Depolarization of T cells by ML7 treatment reduces cell-to-cell transfer 
of virus particles.  
A) Transfer of Gag-YFP fluorescence from infected P2 cells to CMTMR-stained SupT1 
target cells during a 3-h coculture period was measured by flow cytometry. ML7, DMSO, 
or antibodies, along with 10 µg/ml cycloheximide, were added at the beginning of the 
coculture period. Flow cytometry plots are shown. Gate A, CMTMR-labeled target cells; 
gate B, double positive cells representing target cells with transferred Gag-YFP particles; 
and gate C, YFP-expressing cells either fused or conjugated to CMTMR-labeled target 
cells. B) Representative brightfield (top panels) and fluorescence (bottom panels) images 
of cocultures untreated or treated with DMSO or ML7 are shown. Gag-YFP and 
CMTMR signals were shown in green and red, respectively. 
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Figure 2.S4. Examples of polarity index calculations.  
To measure morphological polarization of T cells, outlines of Gag-YFP-expressing P2 
cells were determined by manually tracing the cell perimeter using the ImageJ program. 
Circularity values were then calculated based on this outline using the Measure function 
of ImageJ. The output values range between 0 and 1, with 1 representing a perfect circle. 
To quantify polarity of Gag localization, a 10-segmented grid was placed over each cell 
along the cell's longest axis. The number of segments that contained plasma-membrane-
associated Gag was then used as the polarization index. For clarity, the outline and the 
grid were removed from the lower right panel. 
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Supplementary movies S1-S4: Available on PLoS Pathogens website: 
http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1001167
#s5 
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Chapter III 
 
HIV-1 Gag Associates with a Specific Subset of Uropod-Directed 
Microdomains Determined by Matrix 
 
Abstract 
T cells are one of the natural targets of HIV-1, which primarily spreads in culture 
by cell-to-cell transmission. In lymphoid organs, where cell-to-cell transmission of HIV-1 
likely occurs, T cells often adopt a polarized morphology. In chapter II, HIV-1 Gag was 
found to localize to a rear end protrusion called a uropod of polarized T cells. Uropod 
localization of Gag was driven by NC-mediated multimerization. Uropods participated in 
virological synapses that promote cell-to-cell transmission. Finally, Gag was found to 
associate with uropod-directed microdomains (UDMs), which comigrated rearward with 
Gag to the uropod as T cells polarized. However, the level of multimerization sufficient 
to drive uropod localization, the composition of UDMs and the viral determinants for 
Gag association with UDMs remained vague. Elucidating these mechanisms could lead to 
a better understanding of how HIV-1 traffics and spreads in vivo. In this chapter, a low 
level of multimerization and inner-leaflet binding of Gag to the plasma membrane was 
found to be sufficient to drive Gag localization to uropods. Gag also associated with a 
specific subset of UDMs enriched in the uropod proteins PSGL-1, CD43 and CD44, 
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while excluding other uropod proteins such as ICAM-1, ICAM-3 and the uropod-
associated lipid raft marker CD59. Mechanistically, it was found that this specific UDM 
association is determined by the Gag structural domain matrix (MA).  
 
Introduction 
 HIV-1 spread between cultured T cells is efficiently mediated by cell-to-cell 
transmission[1-5]. T cells in lymphoid organs, where cell-to-cell transmission likely 
occurs, adopt a polarized morphology[6-10]. Therefore, understanding the mechanisms of 
HIV-1 localization, assembly and transmission in polarized T cells could provide better 
insights into how HIV-1 is spread in vivo.  
Polarized T cells form two ends, the leading edge at the front and a protrusion at 
the rear called a uropod. Uropods are enriched in several adhesion molecules including 
PSGL-1, CD43, CD44, ICAM-1, ICAM-3, CD44[11-15], as well as the lipid raft marker 
CD59[11]. Functionally, uropods are important for T cell migration and are known to 
mediate cell-cell contacts[16, 17]. In chapter II it was shown that HIV-1 Gag localizes to 
uropods in polarized T cells, which participated in virological synapses between HIV-1 
infected and uninfected T cells.  
The  HIV-1 structural polyprotein Gag is sufficient to form virus like particles 
(VLPs) [18]. Starting at the N-terminus, Gag is composed of four structural domains: 
matrix (MA), capsid (CA), nucleocapsid (NC) and the late domain p6. MA mediates 
membrane targeting and binding. CA and NC mediate multimerization. CA mediates 
multimerization through a dimerization interface in its C-terminal region[19-23]. NC 
likely mediates multimerization of Gag by binding and utilizing RNA as a scaffold[19, 
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21, 24-26]. NC also recognizes and packages the viral RNA genome[27]. p6 facilitates 
pinching off of virus particles by recruiting the cellular ESCRT complex. 
 MA mediates binding of Gag to the plasma membrane through a bipartite signal. 
The first is an N-terminal myristate moiety that is normally sequestered within MA. 
Through a structural change, the myristate is exposed and inserted into the inner-leaflet of 
the plasma membrane, which increases membrane binding of Gag[28-32]. The second 
signal is a stretch of basic amino acids that form a highly basic region (HBR) on the 
surface of MA[30, 33-36]. The positive charge of the HBR is thought to increase Gag 
association with acidic lipids in the plasma membrane. Residues found within the HBR 
also mediate a direct interaction between Gag and a negatively charged phospholipid, 
phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2], and thereby facilitate Gag 
membrane targeting and binding[37-39]. In this chapter, another function of MA is 
described in which it plays a role in determining microdomain association of Gag. 
Plasma membrane microdomains are dynamic, sub-microscopic clusters of lipids 
and/or proteins. HIV-1 Gag associates with cholesterol and sphingomyelin-enriched 
microdomains called lipid rafts.. Consistent with this notion, Gag has been observed to 
colocalize with GM1[41, 43], a well-known lipid raft marker. Notably, lipid rafts have 
been found to be important for Gag membrane binding and virus assembly[40-42]. For 
example, disrupting lipid rafts by cholesterol depletion results in a reduction of HIV-1 
virus release[41, 44, 45]. Also, another study found that multimerization of Gag 
facilitated its association with microdomains “barges” that were important for virus 
assembly[40]. In addition to lipid rafts, markers for other microdomains also colocalize 
with Gag. For example, tetraspanins such as CD9, CD63, CD81 and CD82, which homo- 
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or hetero-oligomerize to form tetraspanin-enriched microdomains (TEMs), have also 
shown strong colocalization with Gag[46]. Lipid rafts and TEMs are experimentally 
distinguishable by different sensitivities to cholesterol depletion[47] and by 
microscopy[46, 48]. Recently, it was shown by Hogue et. al. that Gag is able to 
reorganize the plasma membrane bring lipid rafts and TEMs together[48]. Therefore, Gag 
may drive the formation of unique microdomains on the plasma membrane.   
 In addition to the role lipid rafts play in virus assembly, TEMs also seem to play a 
role in virus spread. For example, knockdown of CD81 was observed to increase cell-to-
cell transmission[49]. Tetraspanins have been found to be enriched in virological 
synapses[50] and appear to prevent Env-mediated cell-cell fusion[51]. Interestingly, 
knocking down CD81 also decreases virus release, but increases virus infectivity[52]. 
Thus, TEMs may serve a delicate balance of functions that both enhance and inhibit virus 
replication. Further studies are required to better define the function of different TEMs in 
virus spread. 
 Recently, it was observed that Gag associates with another group of 
microdomains termed exosomes/microvesicles (EMVs) or endosome-like domains 
(ELDs) from which exosomes are secreted[53, 54]. It was also determined that 
multimerization and membrane binding are sufficient to drive ELD association[54]. 
Because one of the markers for ELDs is the tetraspanin CD63, it is conceivable that the 
TEMs with which Gag associates represent the same microdomain as ELDs. Notably, 
these observations define a specific microdomain with which Gag associates with, show 
that multimerization is sufficient to drive this localization, and are consistent with a 
model in which the Gag-ELD association drives polarity of ELDs on the plasma 
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membrane[53, 54]. These findings are consistent with the observations and working 
model developed in this thesis.  
 In chapter II it was found that Gag associates with uropod-directed microdomains 
that could carry Gag to the uropod in polarized T cells and that NC-mediated 
multimerization is required for uropod localization. However, the composition of UDMs, 
how Gag associates with them, and the level of multimerization that is sufficient to drive 
Gag localization to uropods remained to be elucidated. Observations made in this chapter 
support a model in which multimerization at the level of tetramerization or higher is 
sufficient to drive Gag localization to uropods and that Gag associates with a specific 
subset of UDMs via an MA-dependent mechanism.  
 
Results 
Virus surfing and membrane curvature are not required for uropod localization. 
In chapter II it was determined that NC-mediated multimerization drives uropod 
localization of Gag. However, what aspects of multimerization drive uropod localization 
were undefined. Gag multimerization is required for membrane curvature and particle 
formation. Virus particles are known to undergo virus surfing, in which they 
unidirectionally migrate on the outer leaflet of the plasma membrane in a receptor- and 
actin/myosin-dependent manner. For example, when Murine Leukemia Virus (MLV) 
particles, another retrovirus, were exogenously added to HEK293 cells, they were 
observed to move on the plasma membrane to the cell body[55]. This was also observed 
for HIV-1 as well as for virus particles pseudotyped with the envelope proteins of avian 
leukosis virus (ALV) or vesicular stomatitis virus (VSV). In addition to exogenously 
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added virus particles, newly formed MLV particles from infected HEK293 cells were 
also observed to undergo surfing[56]. In another study, what appeared to be newly 
formed HIV-1 particles were observed by spinning disk confocal microscopy to form 
outside of cell-cell contact sites followed by lateral localization of these particles to the 
contact sites, which is consistent with virus surfing[57]. Thus, while these experiments 
observed either MLV or HIV-1 in the context of adherent HEK293 cells, it is conceivable 
that this outer-leaflet surfing mechanism could also mediate uropod localization in 
polarized T cells.  
To address the possibility that surfing of virus particles mediates HIV-1 
localization to uropods, two fluorescently tagged CA mutants of Gag were utilized. 
P99A/Gag-YFP and EE75,76AA/Gag-YFP multimerize on the plasma membrane but do 
not efficiently curve the membrane or form virus particles[22, 48, 58](Fig. 3.1A). This 
phenotype is evident in electron micrographs showing electron dense patches of 
P99A/Gag-YFP and EE75,76AA/Gag-YFP in HeLa cells (Fig. 3.1B, images taken by 
Ferri Soheilian and Kunio Nagashima). It should be noted that, while the planar multimer 
phenotype likely also occurs in T cells based on the above micrographs, electron 
microscopy of these mutants should also be done in T cells.  
P99A/Gag-YFP and EE75,76AA/Gag-YFP were expressed in P2 cells by spin 
infection and immunostained for the uropod marker PSGL-1 by copatching. Interestingly, 
both of these planar multimer mutants clearly localized to the uropod (Fig. 3.1C). These 
observations indicate that membrane curvature or particle formation, and hence virus 
surfing on the outer leaflet of the plasma membrane, are not required for uropod 
localization of Gag. Conversely this observation also indicates that multimerization and 
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association with the inner leaflet of the plasma membrane are sufficient for Gag to 
localize to the uropod. 
 
Low level of multimerization is sufficient for Gag polarization towards the uropod. 
For wild type Gag-YFP, multimerization requires both CA and NC. However, a 
Gag-YFP construct that replaces NC with a heterologous dimerizing leucine zipper(LZ)  
sequence (LZ/Gag-YFP) is still capable of multimerizing and forming virus-like particles 
(VLPs)[59-61]. In chapter II, it was shown that LZ/Gag-YFP localizes to the uropod. 
Disrupting the CA dimerization interface in this construct (Fyn(10)/LZ/WMAA/Gag-
YFP), which should only allow LZ-mediated dimerization, caused a loss of uropod 
localization. Because the planar multimer mutants localized so strongly to the uropod, 
these results collectively suggest that uropod localization occurs early in the assembly 
process after Gag dimerization but before membrane curvature. 
To test whether polarized localization of Gag occurs early in assembly, low-order 
Gag multimer mutants were examined. While the LZ sequence normally functions as a 
dimerization motif, specific mutations have been shown to change its oligomerization 
property from a dimer to a trimer(LZ3)[62] or tetramer(LZ4)[63]. Thus, to make trimeric 
and tetrameric Gag, these mutations were introduced into the dimeric LZ/WMAA/Gag-
YFP construct (Fig. 3.2A). The WMAA CA mutations were introduced to ensure that LZ 
was the only interacting domain. However, theses CA mutations decrease 
multimerization and hence the number of myristates available for membrane binding[21, 
64]. To overcome this membrane binding deficiency, the MA mutation 20LK, which is 
known to increase membrane binding[32, 65], was also introduced into the LZ mutant 
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constructs. A monomeric Gag construct containing this 20LK mutation and mutations of 
both the CA dimerization interface and the 15 basic residues of NC 
(20LK/WMAA/14A1G/Gag-YFP) was also examined. This construct is similar to a 
previously described monomeric Gag mutant[66]. 20LK/WMAA/14A1G/Gag-YFP 
(monomer), 20LK/WMAA/LZ/Gag-YFP (dimer), 20LK/WMAA/LZ3/Gag-YFP (trimer) 
and 20LK/WMAA/LZ4/Gag-YFP (tetramer) (Fig. 3.2A) will be referred to hereafter as 
monomeric/, LZ2/, LZ3/ and LZ4/Gag-YFP respectively. 
When expressed in polarized P2 cells, the monomeric/, LZ2/ and LZ3/Gag-YFP 
constructs were observed to localize around the entire plasma membrane. In contrast, 
while LZ4/Gag-YFP was not as polarized as the 20LK/LZ/Gag-YFP positive control, it 
was significantly more polarized than monomeric/, LZ2/ or LZ3/Gag-YFP (Fig. 3.2B). 
Polarization of these mutants in P2 cells is quantified in Fig. 3.2C. These findings suggest 
that uropod localization of Gag occurs early in the assembly process after the 
multimerization of four or more Gag proteins.  
 
Gag associates with a specific subset of uropod-directed microdomains. 
Observations from chapter II suggest that Gag associates with uropod-directed 
microdomains, enriched in the uropod markers CD43 and PSGL-1, that could carry Gag 
to the uropod. Determining the composition of UDMs could lead to a better 
understanding of their function. Thus, in addition to PSGL-1 and CD43, copatching 
between Gag and other uropod-associated proteins ICAM-1, ICAM-3, CD44 and 
CD59[11-14] (Fig. 3.4A-D, top panels) was also examined in unpolarized P2 cells. Gag-
YFP was observed to copatch with PSGL-1 and CD43 as previously observed (quantified 
 112 
but images not shown) and also copatched with CD44 (Fig. 3.3D, lower panel). However, 
Gag did not copatch with ICAM-1, ICAM-3 or CD59 (Fig. 3.3A-C, lower panels). These 
observations are quantified in Fig. 3.3E and indicate that Gag associates with a specific 
subset of UDMs. 
 
Membrane curvature is not required for recruitment of specific UDMs. 
 Because Gag appears to associate with a specific subset of UDMs, it is possible 
that association of Gag with these specific UDMs confers a selective advantage to virus 
replication compared to other UDMs. Thus, the mechanism of Gag association with 
specific UDMs requires further elucidation.  
Membrane curvature can facilitate recruitment of some cell surface proteins[67]. 
It was also recently observed that Gag is able to coalesce microdomains, such as lipid 
rafts and TEMs, that do not normally colocalize. Because membrane curvature was also 
implicated in this Gag-mediated microdomain recruitment[48], it is conceivable that Gag 
associates with specific UDMs that are attracted to membrane curvature as opposed to 
those that are not. 
 To investigate whether specific UDM association by Gag is determined by 
membrane curvature, copatching between the planar multimer mutants P99A/Gag-YFP 
and EE75,76AA/Gag-YFP and the uropod markers PSGL-1, CD43 and CD59 was 
examined in unpolarized P2 cells. Almost identically to wild type Gag-YFP, both of the 
planar multimer mutants were observed to copatch with PSGL-1 and CD43 but not with 
CD59 (Fig. 3.4A-C). Copatching was quantified in Fig. 3.4D. These observations 
indicate that inhibition of membrane curvature does not disrupt the specific UDM 
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association observed for wild type Gag-YFP and that the specificity of UDM association 
is likely determined earlier in the HIV-1 assembly process. 
 
MA determines specificity of UDM association. 
 It is conceivable that while multimerization is required for uropod localization, it 
may not drive the specificity of UDM association. Thus, it is possible that a viral 
component is required in conjunction with multimerization to determine specific UDM 
association. The most likely Gag component to determine UDM specificity would be MA 
because it is the domain of Gag that interacts directly with the plasma membrane. Thus, a 
Gag mutant in which MA was deleted (Fyn(10)/MA/Gag-YFP) was  expressed in P2 
cells and examined for UDM association by copatching analysis. To control for the 
addition of Fyn(10), which is necessary to compensate for the loss of membrane binding 
in the absence of MA, Fyn(10)/MA/Gag-YFP was compared to Fyn(10)/Gag-YFP. 
Strikingly, while Fyn(10)/Gag-YFP appears to associate with the same PSGL-1/CD43-
enriched subset of UDMs as Gag-YFP (Fig. 3.5A), the loss of MA caused Gag to 
segregate from PSGL-1 and CD43 (Fig. 3.5B). Both Fyn(10)/Gag-YFP and 
Fyn(10)/MA/Gag-YFP also did not copatch with ICAM-3 similar to WT (Fig. 3.5A-B). 
Interestingly, copatching between Fyn(10)/MA/Gag-YFP and CD59 was enhanced 
when compared to Fyn(10)/Gag-YFP (Fig. 3.5A-B). Copatching is quantified in Fig. 
3.5C. Together, these data indicate that MA determines the association of Gag with 
specific UDMs.  
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Discussion 
 Uropod localization of HIV-1 Gag requires multimerization. However, it was 
unknown what aspect of multimerization drove this localization. One potential 
mechanism of localization of HIV-1 on the plasma membrane is virus surfing. Surfing 
has been observed for virus particles containing envelope proteins of several viruses 
including MLV, ALV, VSV and HIV-1 in HEK293 cells[55]. However, because the 
planar mutants P99A/Gag-YFP and EE75,76AA/Gag-YFP were observed to localize to 
the uropod, it was determined that membrane curvature, and subsequently virus surfing 
on the plasma membrane, are not required for uropod localization of Gag in polarized T 
cells. It should be noted that, while these results indicate that inner leaflet association is 
sufficient for uropod localization of Gag, it does not exclude the possibility that HIV-1 
virus particles could also surf on the outer leaflet of the plasma membrane to the uropod. 
For example, exogenously added Gag-YFP virus particles that are attached to the cell 
surface, but not fused to the membrane, also localize to the uropod (data not shown). This 
suggests that Gag-YFP particles can surf on the outer leaflet of the plasma membrane to 
the uropod in a manner consistent with  the surfing observed for exogenously added HIV-
1 and MLV particles in HEK293 cells[55]. Virus surfing could also explain the 
observation that unpolarized patches of Gag in unpolarized T cells localize to contact 
sites after the contacts are formed[3, 68]. However, because planar multimer mutants 
localize strongly to the uropod and tetrameric Gag tends to polarize on the plasma 
membrane, it suggests that uropod localization begins at an early stage of the assembly 
process. Supporting this model, the dynamics of HIV-1 assembly have been studied and 
found that after nucleation, a particle forms in roughly 8-9 minutes[69]. In chapter II (fig. 
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1) live cell analysis observing a Gag-YFP-expressing polarized T cell over 20 minutes 
did not show any particles or patches of Gag forming outside of the uropod. This 
observation is consistent with a model in which, in T cells that are already polarized, 
assembling virus particles reach the uropod before virus particle formation is completed. 
It is also possible that virus surfing is not responsible for the  localization of HIV-
1 to the site of cell-cell contacts observed between HEK293 cells[57] or unpolarized T 
cells[3, 68]. For example, because planar multimers still form visible patches and puncta 
on the plasma membrane (Fig. 3.1 and Fig. 3.4) it can not be ruled out that these 
“particles” were not fully formed before the observed migration of HIV-1 to cell-cell 
contact sites occurred. Therefore, these potentially pre-formed particles could have 
utilized the inner-leaflet-associated mechanism that facilitates Gag localization to 
uropods in polarized T cells. Repeating those experiments with planar multimer mutants 
or performing correlative scanning electron microscopy of virus assembly in similar 
experiments is required to determine whether the observed polarized localization to 
contact sites between unpolarized T cells or HEK293 cells is truly due to virus surfing. 
 It was found that Gag associates with a specific subset of UDMs enriched in 
PSGL-1, CD43 and CD44 but not ICAM-1, ICAM-3 or the lipid raft marker CD59. Other 
microdomains, such as lipid rafts and TEMs, have been observed to be important for 
HIV-1 functions including virus assembly/release, spread, and localization[41-43, 46, 
49]. Thus, a possible function of UDMs is to facilitate uropod localization on the plasma 
membrane. As discussed in chapter II, uropod localization of Gag is beneficial to the 
virus because uropods participate in virological synapses and promote cell-to-cell transfer 
of virus particles. However, because ICAM-1, ICAM-3 and CD59 also localize to the 
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uropod, it is conceivable that uropod localization of Gag would also be mediated if Gag 
associated with these uropod proteins. Thus, it is possible that there are other functions of 
CD43/PSGL-1/CD44-enriched UDMs that benefit HIV-1.  
One potential benefit for Gag specifically associating with CD43/PSGL-1/CD44-
enriched UDMs is that crosslinking PSGL-1 is known to activate a signaling pathway 
that results in the increased avidity of the adhesion molecule LFA-1 to its binding partner 
ICAM-1[70]. LFA-1 is enriched in the virological synapse and can promote its 
stability[71]. Thus, it is conceivable that Gag association with PSGL-1 could induce this 
signaling pathway to increase cell-cell adhesion and enhance HIV-1 cell-to-cell 
transmission. Association with other uropod proteins such as the adhesion molecules 
CD43 and CD44 could also enhance virus replication by increasing attachment to target 
cells.  
Because of the potential impact of Gag association with specific UDMs on virus 
replication, it is important to elucidate the mechanism of this interaction. Membrane 
curvature has been implicated in Gag recruitment of different microdomains in HeLa 
cells[48]. However, it was found that MA, not membrane curvature, determined the 
association of Gag with a specific subset of UDMs. One possibility for this MA-mediated 
recruitment of specific UDMs could be the presence of a direct interaction between Gag 
and a UDM-associated protein. In chapter II, myosin was found to be required for 
polarized localization of Gag, indicating that the actin cytoskeleton is important for 
uropod localization. Uropod proteins are linked to the actin cytoskeleton by ERM 
proteins (ref). Thus, it is conceivable that an interaction between Gag and a uropod 
protein could also link multimerizing Gag to the actin cytoskeleton, enabling uropod 
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localization. Alternatively, it can be speculated that Gag association with specific UDMs 
is indirect. For example, the highly basic region (HBR) of MA associates with the 
phospholipid  PI(4,5)P2. If PSGL-1, CD43 and CD44 also have an affinity for PI(4,5)P2, 
then it is conceivable that association of Gag with specific UDMs is based on this shared 
phospholipid association.  
 The finding that Fyn(10)/MA/Gag-YFP localizes to the uropod but does not 
associate with the same specific subset of UDMs as Gag-YFP  or Fyn(10)/Gag-YFP 
suggests that UDM association may not be required for Gag localization to the uropod. In 
conjunction with tetrameric Gag being more polarized than monomeric, dimeric or 
trimeric Gag, and planar multimers localizing to uropods, these observations could 
support a model in which Gag multimerization is the sole factor that drives its 
localization to uropods. However, it is also possible that association with alternative 
UDMs drives Fyn(10)/MA/Gag-YFP localization to uropods. This model is supported 
by the observation that Fyn(10)/MA/Gag-YFP copatches strongly with the uropod-
associated lipid raft marker CD59. It is likely that the association of Fyn(10)/MA/Gag-
YFP with CD59 is driven by the Fyn(10) sequence, which encodes a myristoylation and 
two palmitoylation signals. These acylation signals have been observed to preferentially 
mediate cholesterol-dependent clustering of modified proteins on the plasma membrane. 
These modified proteins associated with DRMs[72], which suggests lipid raft association. 
Thus, it is conceivable that MA actively associates with specific UDMs and overcomes 
the affinity of Fyn(10) for CD59-enriched lipid rafts, while in the absence of MA, 
Fyn(10) facilitates Gag association with CD59-enriched lipid rafts that also transport Gag 
to the uropod. 
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Because of the observations that multimerization drives uropod localization and 
that MA determines specificity of UDM association, it is conceivable that any HIV-1 Gag 
mutant that multimerizes enough to polarize to the uropod and contains MA will 
associate with CD43/PSGL-1/CD44-enriched UDMs. Therefore, the increased 
polarization of LZ4/Gag-YFP suggests that multimerization at the level of a 
tetramerization or higher allows MA-mediated association of Gag with specific UDMs 
that then carry Gag to the uropod. Multimerization-mediated microdomain association is 
consistent with observations by the Gould group that show multimerization is required 
for association of HIV-1 Gag with ELD microdomains[53]. However, LZ4/Gag-YFP 
does not form visible patches or puncta on the cell surface and therefore cannot be 
examined by copatching analyses. Thus, super resolution microscopy, which can detect 
the correlation between two plasma membrane-associated proteins on a nanometer scale, 
is likely required to determine whether tetrameric Gag indeed associates with specific 
UDMs in the future.  
The observations described in this chapter have further defined the relationship 
between Gag multimerization and uropod localization and the association between HIV-1 
Gag and microdomains in biologically relevant polarized T cells. These findings lead to a 
more refined working model of HIV-1 in polarized T cells: When NC-mediated 
multimerizaton reaches the level of tetramerization or higher, Gag associates with 
specific uropod-directed microdomains enriched in CD43, PSGL-1 and CD44 via an 
MA-mediated mechanism. These Gag-associated UDMs then laterally localize on the 
membrane to the uropod where virus particles assemble and accumulate. Uropods then 
mediate contact and VS formation with target cells to facilitate cell-to-cell transmission. 
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(Fig. 3.6). Thus, this chapter defines in much greater detail the role of Gag 
multimerization in uropod localization and elucidates a novel function of MA in 
determining Gag association with a specific subset of uropod-directed microdomains, 
which could have a significant impact on virus replication and spread.  
 
Materials and Methods 
Plasmids 
The HIV-1 molecular clone Gag-YFP was described previously[21, 37]. The 
YFP-tagged planar multimer mutants contain CA mutations P99A or EE75,76AA 
(P99A/Gag-YFP and EE75,76AA/Gag-YFP). They were constructed by standard 
molecular biology techniques to introduce the mutations as described previously[22, 48]. 
Derivatives of pNL4-3/Gag-YFP in which the start codon or the entire MA sequence was 
replaced by 10 amino acids that encode two palmitoyl and a myristoyl signal from Fyn 
kinase, Fyn(10)/Gag-YFP and Fyn(10)/MA/Gag-YFP, respectively, have been 
described previously[37]. The LZ mutants 20LK/WMAA/LZ/Gag-YFP, 
20LK/WMAA/LZ3/Gag-YFP, 20LK/WMAA/LZ4/Gag-YFP, (LZ2/, LZ3/, and 
LZ4/Gag-YFP respectively), were constructed by first introducing LZ into 20LK/Gag-
YFP by standard molecular biology techniques followed by PCR mutagenesis of LZ. All  
mutants were in the context of the pNL4-3 molecular clone of HIV-1[73]. 
 
Copatching Assay 
 P2 cells, a polarized T cell line derived from A3.01 T cell line described 
previously[74], were cultured in RPMI media containing 10% FBS (RPMI-10). Gag-YFP 
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and its derivatives were expressed in P2 cells by spin infection with VSV-G pseudotyped 
virus stocks encoding the Gag derivatives as described previously[74]. Infected cells 
were maintained in RPMI-10 for 2 days. Cells were then resuspended in primary 
antibody, CD43, CD44, PSGL-1, ICAM-1, ICAM-3, or CD59 (BD Biosciences 
Pharmingen. San Diego, CA) and incubated for 30 min at 37°C. Cells were washed in 
RPMI-10 and resuspended in AlexaFluor-594-conjugated goat anti-mouse IgG secondary 
antibody (Invitrogen. Carlsbad, California) for 30 min at 37°C. Cells were then washed, 
fixed in 4% paraformaldehyde and processed for microscopy as previously described[74]. 
For Gag-YFP derivatives, copatching between Gag and UDM marker localized on the 
tops of cells were quantified as described in Chapter II. Because Fyn(10)/MA/Gag-YFP 
localizes to internal compartments as well as the cell membrane, to ensure only plasma 
membrane-associated Gag was quantified for colocalization, images were taken of 
Fyn(10)/Gag-YFP and Fyn(10)/MA/Gag-YFP-expressing cells through the center plain 
of the cell. Quantification was then calculated from Gag and UDM marker on the outer 
edge of the cell using ImageJ and the JaCop plugin as previously described[74].  
 
Polarization calculation 
 Cells expressing monomeric/, LZ2/, LZ3/, LZ4/ or LZ/Gag-YFP were fixed in 4% 
PFA for 20min, washed with PBS-2%FBS and mounted on slides as described above. To 
quantify polarity of Gag localization, a 10-segmented grid was placed over each cell 
along the cell’s longest axis. 10 minus the number of segments that contained plasma 
membrane-associated Gag was then used as the polarization index. Thus a higher number 
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corresponds to higher polarization, with 0 corresponding to Gag distributed over the 
entire plasma membrane.  
 
Nucleofection 
For Gag mutants encoding Fyn(10) on their N-terminus, nucleofection of the DNA by 
Amaxa kit V was used to express these mutants in P2 cells because virus stocks of these 
mutants have low infectivity. Briefly, 1x10
6
 P2 cells were resuspended in 100l Amaxa 
V solution and transferred to a cuvette. Program C-016 was used to electroporate the 
samples. Transfected cells were added to 2ml RPMI-10 and cultured for 3 days before 
immunostaining experiments were performed.  
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Figure 3.1. Membrane curvature or particle formation is not required for uropod 
localization.  A) Cartoon indicating the step in Gag assembly that is inhibited by the CA 
mutations P99A and EE75,76AA. B) Electron micrographs of HeLa cells expressing 
P99A/Gag-YFP (left panel) or EE75,76AA/Gag-YFP (right panel). Note the electron 
dense patches of Gag but lack of virus-like particles. C) P2 were infected with VSVG-
pseudotyped virus particles encoding P99A/Gag-YFP (upper panel) or EE75,76AA/Gag-
YFP (lower panel) and immunostained for PSGL-1 by copatching. Infected polarized 
cells were observed to determine uropod localization. 
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Figure 3.2. LZ4/Gag-YFP polarizes more than monomeric/, LZ2/ or LZ3/Gag-YFP. 
A) Illustration of low-order multimer Leucine Zipper (LZ) mutants. Mutations (denoted 
by red letters) were made in the sequence of the dimeric leucine zipper sequence to 
generate what are expected to be trimeric and tetrameric LZ sequences. These LZ 
sequences were inserted in place of NC. The CA mutation, WM184,185AA (WMAA, 
denoted by two X), prevents CA-mediated dimerization and was introduced into the 
constructs to ensure that LZ provides the only Gag-Gag interaction. All constructs 
contain the MA mutation 20LK, which increases membrane binding. B) Monomeric/Gag-
YFP, containing mutations in the CA dimerization interface and 15 basic residues in NC, 
LZ2/, LZ3/, LZ4/Gag-YFP, and an LZ/Gag-YFP construct that multimerizes and forms 
particles were packaged into VSV-G-pseudotyped virus particles and used to infect P2 
cells. C) Polarity of the mutants in polarized P2 cells was measured as the amount of cell 
perimeter not covered by Gag. Error bars represent standard error of the mean. 
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Figure 3.3. Gag associates with a specific subset of uropod-directed microdomains. 
P2 cells were infected with a VSVG-pseudotyped virus encoding Gag-YFP. Cells were 
immunostained by copatching assay for A) ICAM-1, B) ICAM-3, C) CD59 and D) 
CD44. Polarized cells were observed to confirm that the uropod proteins were enriched at 
the uropod (A-D, top panels) and unpolarized cells were examined to observe whether 
uropod markers were enriched in Gag-associated UDMs (A-D, bottom panels). E) The 
level of copatching between Gag and uropod markers was measured by the square of 
Pearson’s correlation coefficient. n=the number of cells used in calculations. Error bars 
represent standard error of the mean.  
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Figure 3.4. Membrane curvature is not required for specific UDM association. 
P2 cells were infected with VSV-G-pseudotyped virus particles encoding the planar 
multimer mutants P99A/Gag-YFP (A-C, top panels) and EE75,76AA/Gag-YFP (A-C, 
bottom panels). These cells were immunostained for A) PSGL-1, B) CD43 or C) CD59 
by copatching. D) The level of copatching between Gag and uropod markers was 
calculated using the square of Pearson’s correlation coefficient. n=the number of cells 
used in calculations. Error bars represent standard error of the mean.  
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Figure 3.5. Gag association with specific UDMs is determined by MA. 
P2 cells were transfected by Amaxa nucleofection with DNA encoding A) Fyn(10)/Gag-
YFP or B) Fyn(10)/MA/Gag-YFP. Cells were immunostained by copatching for PSGL-
1, CD43, ICAM-3 or CD59. C) The level of copatching between Gag and uropod 
markers was calculated using the square of Pearson’s correlation coefficient. n=the 
number of cells used in calculations. Error bars represent standard error of the mean.  
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Figure 3.6. Working Model. 
When NC-mediated multimerizaton reaches the level of tetramerization or higher, 
Gag associates with specific uropod-directed microdomains enriched in CD43, PSGL-1 
and CD44 via an MA-mediated mechanism. These Gag-associated UDMs then laterally 
localize on the membrane to the uropod where virus particles assemble and accumulate. 
Uropods then mediate contact and VS formation with target cells to facilitate cell-to-cell 
transmission. 
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Chapter IV 
 
 
Discussion 
 
 
Rationale 
 HIV-1 was discovered to be the causative agent of AIDS almost 30 years ago. 
Since then, a vast amount of research has been done to elucidate the mechanisms by 
which HIV-1 assembles, interacts with its host cells and the immune system, and how 
HIV-1 spreads between people and among the natural target cells within those people. 
Cell-to-cell transmission between T cells is now recognized as the primary mode of HIV-
1 spread in tissue culture, as it is up to several thousand times more efficient than cell-
free transmission[1-5]. In lymphoid organs, where cell-to-cell transmission likely occurs, 
T cells often adopt a polarized morphology[6-11]. Thus, determining the relationship 
between HIV-1 and polarized T cells could help elucidate how the virus spreads in vivo. 
However, few studies have been conducted to determine the mechanisms of HIV-1 
localization and spread in polarized T cells. The work done in this thesis defines the 
mechanisms of Gag localization to a rear end protrusion of polarized T cells called a 
uropod, the role uropods play in cell-cell transfer of virus particles and the relationship 
between Gag and uropod-directed microdomains on the plasma membrane.  
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Summary of results 
 
Chapter II  
In chapter II, it was shown that Gag localizes to uropods in polarized T cells by 
immunostaining Gag-YFP-expressing primary T cells and a polarized T cell line, P2, for 
three uropod markers. It was also shown that patches of Gag at the uropod contain 
proteolytically cleaved MA as well as the Env glycoprotein, indicating that a subset of 
these uropod-localized Gag patches contain mature and likely infectious HIV-1 particles. 
This uropod localization was also stably maintained in live migrating T cells observed for 
over 20 minutes. 
Uropods in uninfected T cells are enriched in adhesion molecules and are known 
to mediate contact with other cells[12-14]. It was determined in chapter II that HIV-1 
Gag-containing uropods could also maintain stable contacts with target cells using live 
cell analyses.  A cell-cell contact assay also showed that uropods of HIV-1-infected T 
cells preferentially mediated contacts with target cells over non-uropod contacts by a 2:1 
ratio. This was especially significant considering the uropod accounts for only 20-30% of 
the cell surface. It was then examined whether any of these contacts formed virological 
synapses (VSs), which are contact junctions between infected and uninfected cells that 
mediate cell-to-cell transmission[1, 3, 15-18]. VS formation was identified by the 
accumulation of the virus receptor CD4 on target cells. Gag-YFP-expressing P2 cells, 
immunostained for the uropod marker CD43, were co-cultured with SupT1 cells that 
were immunostained for CD4 and cell-cell contacts were observed after 3 hours. This 
experiment revealed that CD4 was enriched at contacts containing Gag and CD43 but not 
at non-CD43-containing contacts or CD43 contacts of uninfected cells, indicating that 
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uropods participate in virological synapses. Furthermore, a myosin light chain kinase 
inhibitor ML7 that depolarizes cells and Gag was found to inhibit cell-cell transfer of 
virus particles. This indicates that the cytoskeleton plays a role in Gag polarization and 
that uropods or cell polarity enhance cell-to-cell transfer of virus particles. 
 The observations above indicate that the uropod plays an important biological 
function for HIV-1 transmission. Thus, understanding the mechanism by which uropod 
localization occurs is important. In chapter II, by copatching and live cell analyses, it was 
found that Gag associates with uropod-directed microdomains (UDMs). Specifically, Gag 
copatched with the uropod markers PSGL-1 and CD43 in both polarized and unpolarized 
T cells, and Gag/PSGL-1 patches were observed by live-cell microscopy to move 
rearward to the uropod as T cells polarized. Together, these data suggest that Gag 
associates with UDMs that carry Gag to the uropod.   
To determine the viral components required to drive uropod localization, 
mutational analyses of Gag were performed. MA, CA and Env were found to be 
dispensable for localization of Gag to the uropod. However, deleting NC or mutating the 
basic residues of NC caused Gag to localize around the entire plasma membrane. This 
observation indicated that NC is required for uropod localization of Gag. It was possible 
that NC-dependent uropod localization was due to either NC-mediated multimerization, 
driven by NC utilizing RNA as a scaffold[19-25], or a protein-NC interaction. Thus, the 
mechanism of NC-mediated uropod localization was further elucidated by replacing NC 
with a heterologous dimerizing sequence, leucine zipper (LZ). This LZ mutant (LZ/Gag-
YFP) multimerizes and forms particles[26-28], but LZ has no sequence homology to NC. 
LZ/Gag-YFP, but not the dimeric LZ/WMAA/Gag-YFP, rescued localization of Gag to 
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the uropod. Thus, NC-mediated higher-order multimerization (more than a dimer), and 
not an interaction between a cellular protein and NC, is required for uropod localization. 
 
Chapter III 
While multimerization drives uropod localization of Gag, the exact aspect of 
multimerization and the level of multimerization required for uropod localization were 
unknown. Also, while Gag was observed to associate with UDMs, the composition of the 
UDMs and the mechanisms that facilitate UDM association of Gag were undefined. 
Thus, chapter III aimed to further elucidate the mechanisms of multimerization-mediated 
uropod localization of Gag, the composition of UDMs and the viral determinants of 
UDM association. 
A possible mechanism for uropod localization is that fully formed particles, which 
require Gag multimerization, could be caught in retrograde membrane actin flow or 
“surf” on the outer leaflet of the plasma membrane. However, it was observed that two 
Gag mutants containing CA mutations that allow multimerization but inhibit membrane 
curvature and particle formation, P99A[29-31] and EE75,76AA[32, 33], localized to the 
uropod. This indicates that membrane curvature, and hence virus particle formation or 
surfing of completed particles, is not necessary for uropod localization of Gag. It also 
indicates that multimerization and an association with the inner-leaflet of the plasma 
membrane is sufficient to drive uropod localization. 
Because membrane curvature is not required for uropod localization, it was 
possible that uropod localization of Gag occurs at an early stage in virus assembly. To 
determine what level of multimerization is sufficient to drive uropod localization of Gag, 
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the localization of monomeric/, LZ2/, LZ3/ and LZ4/Gag-YFP, which are expected to be 
monomeric, dimeric, trimeric and tetrameric Gag respectively, was examined in polarized 
T cells. LZ4/Gag-YFP was observed to be much more polarized than monomeric/, LZ2/ 
or LZ3/Gag-YFP, suggesting that a relatively low order of multimerization is sufficient to 
drive localization of Gag to the uropod.  
Gag association with UDMs was established in chapter II based on the copatching 
of Gag with two uropod markers, PSGL-1 and CD43. However, there are several other 
known uropod proteins that UDMs could be composed of including CD44, ICAM-1, 
ICAM-3 and the lipid raft marker CD59. Interestingly, CD44 was found to copatch with 
Gag similarly to PSGL-1 and CD43 while ICAM-1, ICAM-3 and CD59 did not. These 
results indicate that Gag associates with only a specific subset of UDMs.  
Previous studies have shown that Gag is able to coalesce lipid rafts and 
tetraspanins together that normally segregate in HeLa cells[31, 34], but that a planar 
multimer mutant does not mediate this coalescence[31]. This suggests that Gag 
differentially recruits various microdomains in a step-wise manner that could be based on 
membrane curvature. Thus, it was conceivable that membrane curvature could facilitate 
recruitment of CD43/PSGL-1/CD44-enriched UDMs but not ICAM-1, ICAM-3 or 
CD59-enriched UDMs. However, it was found that the planar multimer mutants 
P99A/Gag-YFP and EE75,76AA/Gag-YFP associated with PSGL-1- and CD43- but not 
CD59-enriched UDMs similar to wild type Gag-YFP, indicating that UDM association 
occurs earlier in assembly before membrane curvature and by an alternative mechanism.  
Because MA mediates membrane binding through its myristoyl group and highly 
basic region (HBR)[35-42], it was the likeliest part of Gag to facilitate specific UDM 
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association. Therefore, it was tested whether deleting MA would decrease CD43/PSGL-
1/CD44-enriched UDM association. Interestingly, while Fyn(10)/Gag-YFP associated 
with CD43- and PSGL-1-enriched UDMs similarly to WT Gag-YFP, it was observed that 
Fyn(10)/MA/Gag-YFP did not. Also, Fyn(10)/MA/Gag-YFP showed an increase in 
CD59-enriched UDM association, which was not observed for WT Gag-YFP or 
Fyn(10)/Gag-YFP. Together, these data indicate that Gag associates with specific UDMs 
by an MA-dependent mechanism. 
The findings from Chapter II and chapter III lead to a current working model for 
how HIV-1 localizes and is spread in polarized T cells: When NC-mediated 
multimerizaton reaches the level of tetramerization or higher, Gag associates with 
specific uropod-directed microdomains enriched in CD43, PSGL-1 and CD44 via an 
MA-mediated mechanism. These Gag-associated UDMs then laterally localize on the 
membrane to the uropod where virus particles assemble and accumulate. Uropods then 
mediate contact and VS formation with target cells to facilitate cell-to-cell transmission. 
Thus, the observations described in this thesis provide new and biologically 
relevant insights into the potential mechanisms that HIV-1 utilizes to localize and spread 
between T cells in vivo and enhance our understanding of the relationship between Gag 
and the plasma membrane. 
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Future Directions 
What are the dynamics of uropod-mediated contacts and VS formation? 
 VSs between T cells were found to be enriched in the uropod marker CD43, 
indicating that uropods participate in virological synapses. However, there are 
unanswered questions about the dynamics of uropod association with the VS. In 
particular, it remains unknown whether uropods mediate initial contact in the formation 
of the VS. Uropods  are enriched in adhesion molecules, and uropods of HIV-1 infected 
T cells appear to preferentially mediate contacts with target cells at steady state. Thus, it 
is conceivable that uropods of HIV-1 infected T cells mediate initial contact with target 
cells. In this model, uropods would act as preformed platforms that form a VS soon after 
contact occurs. However, a mechanism of VS formation in which the initial contact 
occurs at another part of the cell is also possible. For example, the initial contact by an 
HIV-1 infected T cell could primarily occur at its leading edge, followed by reorientation 
of the cell to subsequently attach to the target cell via its uropod. In unpolarized cells, it 
has been shown that Gag patches can localize to a cell-cell contact site after contact 
occurs[3, 17]. This mechanism of Gag polarization to the VS in morphologically 
unpolarized T cells could utilize the same cellular machinery required to form uropods. 
Thus, the VSs that form between unpolarized cells could represent the polar cap where a 
uropod would form if the T cell were to polarize. Therefore, the original cell-cell 
interaction observed in these previous studies could represent a “non-uropod contact,” 
followed by subsequent reorientation of the cell and cell machinery to form the “uropod 
contact” and the VS. Because T cells are constantly migrating and adopt a polarized 
morphology in lymphoid organs[6-11], determining the frequency of uropod and non-
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uropod contacts and how they affect the formation of the VS would help to better 
understand the dynamics of HIV-1 cell-to-cell transmission in vivo.  
 To determine the dynamic relationship between uropods and VS 
formation, long-term live-cell microscopy could be used. Gag-YFP-expressing T cells 
could be immunostained for uropod markers such as PSGL-1 and co-cultured with 
another T cell line constitutively expressing fluorescently tagged CD4 (CD4-YFP). To 
prevent off target activation effects that could be caused by antibody crosslinking, Fab 
fragments that do not cause crosslinking could be used as the primary antibody. These 
co-cultured cells would then be observed by live-cell microscopy to determine the 
dynamics of uropod-mediated cell-cell contacts and VS formation. The time frame likely 
required to observe VS formation would be up to 3 hours based on the experiments in 
chapter II, in which virological synapses were observed after 3 hours of co-culture. 
 In the virological synapse studies that were discussed in chapter II, CD4-
expressing target cells were immunostained with a fluorescently tagged primary 
antibody. In this approach, only one image of each cell was required for identifying VSs. 
However, the fluorescence signal of the FITC-conjugated CD4 antibody used in this 
approach was low and photobleached quickly, presenting a major obstacle to long-term 
live-cell microscopy. In contrast, YFP that is tagged to CD4 fluoresces more brightly 
than the FITC-conjugated antibody and does not photobleach as quickly. These properties 
make CD4-YFP more useful than CD4 immunostaining for long-term live-cell 
microscopy analyses of VS formation. To ensure that tagging of CD4 with YFP does not 
affect its function, HeLa and T cells were transfected with a plasmid encoding CD4-YFP. 
As expected of functioning CD4, CD4-YFP was found to be localized on the plasma 
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membrane in both transfected HeLa cells and in T cells (Fig. 4.1A-B). Furthermore, 
expression of CD4-YFP also increased the susceptibility of HeLa cells, which do not 
normally express CD4, to infection by pNL4-3-derived HIV-1 virus particles to a similar 
level as untagged CD4 (Fig. 4.1C). Together, these observations indicate that the addition 
of YFP to CD4 does not inhibit its function as a receptor for HIV-1 and thus could be 
used to study virological synapses.  
For long-term live-cell microscopy, maintaining cell viability is critical. Three 
factors that affect cell health and viability are temperature, phototoxicity and pH changes 
that occur when cell culture medium is exposed to the air while on the microscope stage. 
While culture at room temperature is not lethal to the cells, cell processes slow down, and 
cell morphology can be altered. Maintaining cells at 37°C while on the microscope stage 
can be accomplished by utilizing a temperature-controlled closed chamber. CO2 is 
required to maintain the pH of commonly used culture media buffered with NaHCO3. 
Thus, when exposed to the air, this culture medium can become alkaline and adversely 
affect cells. Overcoming the loss of CO2 can be achieved by placing the cells in a closed 
chamber and adding 5% CO2 directly into it. Alternatively, CO2-independent media 
containing HEPES or phosphate buffer, which resists pH changes without CO2, is 
commercially available. While not all cells grow well in this media, similar studies that 
examined cell-cell transfer of virus particles between T cells by live-cell microscopy have 
utilized CO2-independent media[3]. Finally, phototoxicity occurs when the excitation 
light splits oxygen molecules (O2) into singlet oxygen or other reactive oxygen species 
that are harmful to cells. Shorter exposure times, longer periods between exposures and 
lower energy levels of the excitation light can be used to mitigate phototoxicity. In 
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conjunction with these steps, the oxygen level of the media can be reduced either through 
scavengers such as ascorbic acid or a derivative of vitamin E called Trolox or by a 
commercially available oxygen depletion system such as Oxyrase. The microscope itself 
has a major impact on the level of light required to clearly observe fluorescence. 
Spinning disc confocal microscopes can detect very low levels of light compared to 
epifluorescence microscopes, drastically reducing phototoxicity and photobleaching. 
However, an epifluorescence microscope was also successfully used in chapter II to 
observe live cells. While the time frame for those experiments, 30 min to 1 hour, was 
shorter than the 3 hour time frame likely required for the long-term live-cell microscopy 
experiments proposed above, the implementation of oxygen-reducing systems and 
addition of CO2 and/or CO2-independent media would allow a greatly increased time 
frame to observe cell-cell contacts and VS formation. 
 Under these conditions, long-term live-cell microscopy could be used to quantify 
1) the ratio of initial contacts mediated by uropods to initial contacts mediated by the 
leading edge of Gag/YFP-expressing T cells, 2) whether Gag/YFP-expressing T cells 
reorient themselves to form uropod contacts if the initial contact is not mediated by the 
uropod, and if so, how long this process takes, and 3) the time to VS formation after the 
initial contact is made as measured by CD4 accumulation. Depending on the level of 
success of increasing the length of time that cells could be observed, the average duration 
of the VS could also be measured. Thus, these observations would determine whether 
uropods act as preformed platforms for HIV-1 that directly contacts target cells to form a 
VS, and provide insights into the mechanism and dynamics of VS formation in 
biologically relevant polarized T cells. 
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What is the mechanism by which MA determines specific UDM association? 
 In chapter III, MA was found to determine the specificity of UDM association by 
Gag. In the presence of MA, Fyn(10)/Gag-YFP associated with PSGL-1/CD43-enriched 
UDMs, and segregated from CD59- and ICAM-3-enriched UDMs. In the absence of MA, 
Gag lost its association with PSGL-1 and CD43, stayed segregated from ICAM-3, but 
gained an association with CD59. These observations elucidated a new function of MA in 
which MA determines Gag association with a specific subset of UDMs. Understanding 
this mechanism could lead to better insights into the relationship between Gag and 
plasma membrane microdomains and their function, specifically the role of UDMs in 
HIV-1 replication in polarized T cells.  
Even though Fyn(10)/Gag-YFP and Fyn(10)/MA/Gag-YFP have both had the 
acylation status of their MA altered by the addition of Fyn(10), these two mutants 
associated with different UDMs. Thus, the specificity of UDM association is likely due to 
the MA sequence itself and not the acylation status of MA. One of the other features of 
MA is the highly basic region (HBR). The HBR is known to be important for membrane 
binding[35, 37-39, 41, 42]. Potentially, the positively charged amino acids in the HBR 
could interact with specific negatively charged phospholipids to which some, but not all, 
uropod proteins are also attracted. Thus, it is conceivable that when Gag multimerizes, it 
clusters these acidic phospholipids and specific uropod proteins together. For example, 
the HBR mediates binding of Gag to the acidic phospholipid phosphoinositol-(4,5)-
bisphosphate [PI(4,5)P2], which has been observed to mediate clustering of plasma 
membrane proteins into microdomains[43]. Thus, it is conceivable that PI(4,5)P2, which 
Gag directly binds to, mediates clustering of  PSGL-1, CD43 and CD44, but not ICAM-1, 
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ICAM-3 or CD59. Alternatively, a direct interaction between a UDM protein and MA 
could also determine specific UDM association of Gag. Further mutational analysis of 
MA, discussed below, can be done to distinguish these possibilities.  
First, to determine whether the HBR plays a role in specific UDM association, the 
8 basic residues within the HBR of Fyn(10)/Gag-YFP could be mutated to neutral amino 
acids like alanine and threonine (Fyn(10)/6A2T/Gag-YFP). If Fyn(10)/6A2T/Gag-YFP 
lost its association with CD43/PSGL-1/CD44-enriched UDMs similarly to 
Fyn(10)/MA/Gag-YFP, then it would indicate that the HBR is required for specific 
UDM association. In this case, to determine whether it is the positive charge of the HBR 
that determines specific UDM association, an HBR R/K switch mutant could be made in 
which the two Lys(K) are mutated to Arg(R) and the six Arg are mutated to Lys 
(HBR/RKswitch/Gag-YFP). This mutant would maintain the same overall charge as wild 
type Gag-YFP, but likely disrupt any direct interactions between Gag and UDM-
associated proteins. If this mutant associated with CD43/PSGL-1/CD44-enriched UDMs, 
it would indicate that the positive charge of the HBR plays a major role in specific UDM 
recruitment. If HBR/RKswitch/Gag-YFP did not copatch with CD43/PSGL-1/CD44-
enriched UDMs, it would suggest that a direct interaction between the HBR and either 
PI(4,5)P2 or a UDM protein was occurring. To determine whether Gag association with 
PI(4,5)P2 is required for specific UDM association, a mutant in which MA is replaced by 
the PI(4,5)P2-binding PH-domain could be examined for UDM association. If this 
construct, which should bind PI(4,5)P2 but lacks MA, was observed to copatch with 
CD43/PSGL-1/CD44-enriched UDMs it would indicate that PI(4,5)P2 association of Gag 
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determines UDM association. If not, it would suggest instead that specific UDM 
association of Gag is determined by an interaction between MA and a UDM protein. 
Alternatively, if the HBR mutant Fyn(10)/6A2T/Gag-YFP still associated with 
CD43/PSGL-1/CD44-enriched UDMs in T cells, then it would be concluded that another 
part of MA, not the HBR, determines specific UDM association. This would also suggest 
that a direct interaction between a UDM protein and some part of MA was occurring. In 
this case, deletion mutants could be made to determine the region of MA required for 
specific UDM association. 
 In the cases suggesting a direct interaction between MA and a UDM protein, once 
the region of MA that determines specific UDM association was identified, co-
immunoprecipitation experiments between uropod proteins and these mutants, with WT 
Gag-YFP as the positive control, could be done to determine which, if any, uropod 
proteins MA interacts with. Candidate proteins would include the UDM markers with 
which Gag has already been observed to associate (PSGL-1, CD43 and CD44). Other 
candidates would include the Ezrin/Radixin/Moesin (ERM) proteins. ERMs are 
scaffolding proteins that are known to link the cytoplasmic tails of uropod-associated 
proteins, including PSGL-1, CD43 and CD44, to the actin cytoskeleton and are involved 
in their localization to uropods[44-47].  
If a direct interaction between Gag and a uropod-associated protein is found, 
shRNA knockdowns of the identified protein could be done to determine whether this 
association mediates specific UDM recruitment and/or uropod localization of Gag. If the 
specificity of UDM association and/or uropod localization of Gag are found to be 
mediated by this direct interaction, it would then be possible to test the importance of 
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specific UDM association and/or uropod localization of Gag to virus replication. For 
example, T cells that express wild type Gag-YFP, and in which the identified UDM 
protein is knocked down by shRNA, could be used in functional assays such as cell-cell 
transfer, virus release and infectivity of virus particles. 
 
Do individual UDM proteins enhance virus replication and spread? 
 It is conceivable that the benefit of Gag association with specific UDMs is 
conferred by a single UDM protein, such as CD43, PSGL-1 or CD44. If this is the case, it 
is also possible that knocking down that beneficial UDM protein disrupts a process other 
than Gag association with UDMs or uropod localization. Thus, while disrupting UDM 
association of wild type Gag is the best way to determine the role of UDMs in virus 
replication, it is possible and valuable to test the role of individual UDM proteins in these 
processes as well. For example, because the UDM proteins that Gag associates with are 
adhesion molecules, it is possible that these particular adhesion molecules promote cell-
to-cell transfer of HIV-1 between T cells. Thus, to determine whether PSGL-1, CD43 or 
CD44 enhance cell-cell transfer of virus particles, T cells in which these UDM proteins 
are knocked down by shRNA can be used as donor cells in the cell-cell transfer assay 
described in chapter II.   
The first candidate to be tested would be PSGL-1, because activation of PSGL-1 
has been observed to cause a signaling cascade that results in increased avidity of LFA-1 
to its binding partner ICAM-1[48, 49]. LFA-1 is an important adhesion molecule that has 
been observed to promote cell-to-cell transmission by stabilizing VSs, where it has been 
found to be enriched[50]. LFA-1 and its binding partner ICAM-1 have also been 
 148 
implicated in virus infectivity and spread[51]. Because PSGL-1 has been observed to be 
activated by antibody crosslinking[49], it is conceivable that multimerizing Gag could 
also activate PSGL-1 and in turn lead to increased avidity of LFA-1, thereby enhancing 
cell-to-cell transmission. 
To determine whether Gag facilitates PSGL-1-mediated signaling of LFA-1 
activation in order to enhance cell-to-cell transmission, the first step would be to examine 
whether PSGL-1 enhances cell-to-cell transfer of virus particles. Gag-YFP-expressing P2 
cells, in which PSGL-1 is knocked down, could be used as donor cells in the cell-cell 
transfer assay described in chapter II. If cell-to-cell transfer of virus particles is 
unaffected by PSGL-1 knockdown, then other uropod proteins would be individually 
tested for an effect on cell-to-cell transfer of virus particles. But if cell-to-cell transfer of 
virus particles is found to be reduced when PSGL-1 is knocked down, it would indicate 
that PSGL-1 enhances cell-cell transfer, potentially through activation of LFA-1. If so, a 
series of experiments could be done to determine whether PSGL-1-mediated 
enhancement of cell-to-cell virus transfer was due to LFA-1 activation (see figure 4.2 for 
flow chart).  
The next step would be to determine whether Gag/YFP leads to the activation of 
LFA-1. This could be done by immunostaining Gag-YFP-expressing T cells with an 
antibody specific to activated LFA-1. If LFA-1 was not activated in the Gag/YFP-
expressing T cells, then it would be likely that PSGL-1 enhances cell-to-cell transfer 
based on its own adhesive properties or that PSGL-1 activates other signaling pathways 
that facilitate cell-to-cell virus transfer. But if LFA-1 was found to be activated in T cells 
when Gag-YFP was expressed, whether this Gag-YFP-mediated LFA-1 activation was 
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due to PSGL-1 could then be determined by knocking down PSGL-1 in Gag-YFP-
expressing T cells and observing whether LFA-1 remained activated. If LFA-1 was not 
activated in Gag/YFP-expressing cells in which PSGL-1 is knocked down, it would 
indicate that LFA-1 is activated by HIV-1 through another mechanism, possibly by 
another HIV-1 protein. But if LFA-1 activation was observed to be decreased in 
Gag/YFP-expressing cells when PSGL-1 is knocked down, whether LFA-1 enhances 
cell-cell transfer of virus particles could then be tested directly. This could be done by 
knocking down LFA-1 in donor cells expressing Gag-YFP and observing whether cell-to-
cell transfer to target cells was decreased. If cell-to-cell transfer of virus particles is not 
affected by LFA-1 knockdown, it would indicate that LFA-1 activation is likely an off-
target effect of Gag-YFP-mediated PSGL-1 activation but not involved in virus spread 
and that PSGL-1 enhances cell-to-cell transfer by another mechanism. But if cell-to-cell 
transmission of HIV-1 is decreased when LFA-1 is knocked down it would be possible 
that LFA-1 and PSGL-1 independently enhance cell-to-cell transfer of virus particles. 
Thus, if LFA-1 was observed to enhance cell-to-cell transfer of virus particles, the 
efficiency of cell-to-cell transfer of virus particles could be compared between donor 
cells in which PSGL-1 and LFA-1 are individually or simultaneously knocked down. If 
no or little difference is observed between cells that have both PSGL-1 and LFA-1 
knocked down and cells with PSGL-1 or LFA-1 knocked down individually, then these 
observations combined would define a mechanism in which Gag crosslinks PSGL-1, 
which signals LFA-1 to increase its avidity to its binding partners, thereby enhancing 
cell-to-cell transfer of virus particles.  
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Does Gag associate with pre-existing uropod-directed microdomains? 
 In chapter III it was observed that Gag associates with PSGL-1/CD43/CD44-
enriched UDMs but not ICAM-1-, ICAM-3- or CD59-enriched UDMs by an MA-
dependent mechanism. However, it is unknown whether this association is driven by Gag 
recruitment of these UDMs or whether CD43/PSGL-1/CD44-enriched UDMs exist on the 
membrane even in the absence of Gag. Notably, it was recently shown that Gag coalesces 
existing microdomains that do not normally associate with each other in HeLa cells[31, 
34]. Thus, it is possible that a similar mechanism occurs in T cells in which Gag 
coalesces separate UDMs.  
It is of note however, that the relationship between Gag and microdomains are 
likely different between HeLa and T cells. For example, Gag colocalizes with CD59 in 
HeLa cells[31], but not in T cells. It is conceivable that this difference in microdomain 
association is caused by a differential expression of proteins important for microdomain 
association. For example, Gag associates with PSGL-1-enriched UDMs in T cells. 
However, HeLa cells do not express PSGL-1 (Fig. 4.3A). Thus, if PSGL-1 is a driving 
factor for Gag association with UDMs in T cells, the lack of PSGL-1 could account for 
the CD59 association of Gag in HeLa cells. Interestingly, when PSGL-1 is expressed via 
DNA plasmid in HeLa cells (Fig. 4.3B) it colocalizes with Gag (Fig. 4.3C), recapitulating 
the UDM association of Gag observed in T cells. It would thus also be interesting to 
examine whether this PSGL-1 expression disrupts Gag colocalization with CD59 in HeLa 
cells.  
To determine whether UDMs pre-exist in the absence of Gag, or whether Gag 
coalesces different UDMs together, copatching analysis of UDM proteins in uninfected 
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P2 cells could be done. By utilizing different antibody isotypes with isotype-specific 
secondary antibodies, it could be determined whether CD43/PSGL-1/CD44-enriched 
microdomains exist in the absence of Gag or whether Gag coalesces these uropod 
proteins together.  
In preliminary experiments, it was tested whether CD44 copatches with itself 
(positive control), CD43, PSGL-1, ICAM-1 or ICAM-3. It was observed that CD44 
copatched with itself, PSGL-1 and CD43 and segregated from ICAM-1 (Fig. 4.4A-D). 
These observations would be expected if Gag-associated UDMs pre-exist on the plasma 
membrane. However, an interesting result was also observed in which CD44 copatched 
with ICAM-3 (Fig. 4.4E). These results are quantified in Fig. 4.4F. ICAM-3 does not 
copatch with Gag, as described in chapter III. Thus, this observation indicates that Gag 
associates with a specific pre-existing UDM and then reorganizes it by actively excluding 
some proteins from that UDM. Supporting this conclusion, it was observed that in cells 
expressing Gag-CFP, Gag copatched with CD44, but the colocalization of CD44 and 
ICAM-3 that had been observed in uninfected P2 cells was lost (Fig. 4.5A-B). These 
results are quantified in Fig. 4.5C.  
To further examine this mechanism, Fyn(10)/MA/Gag-YFP could be used. 
Because Fyn(10)/MA/Gag-YFP does not copatch with CD43/PSGL-1/CD44-enriched 
UDMs, it would be expected that CD44 and ICAM-3 should remain copatched in cells 
expressing Fyn(10)/MA/Gag-YFP similarly to uninfected cells. . If this was observed, 
combined with the previous observations, it would show that Gag reorganizes the plasma 
membrane by recruiting CD43, PSGL-1, and CD44, but actively segregating ICAM-3 
from pre-existing UDMs and that this mechanism is dependant on MA. However, if it 
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was observed that ICAM-3 and CD44 did not copatch in the presence of 
Fyn(10)/MA/Gag-YFP it would also be interesting as it would indicate that another 
HIV-1 protein could be playing a crucial role in plasma membrane microdomain 
organization and potentially open a major new direction in HIV-1 research. 
While reorganization of plasma membrane microdomains has been observed 
previously, in which different microdomains are coalesced by Gag[31, 34], this process 
could be attributed to a non-specific mechanism in which multimerization on the 
membrane simply attracts various microdomains. However, in this case the observation 
that Gag could split existing microdomains apart reveals a new and novel mechanism by 
which HIV-1 actively rearranges the plasma membrane.  
  
When does UDM association occur? 
 In chapter III, it was observed that LZ4/Gag-YFP polarizes more than 
monomeric/, LZ2/ or LZ3/Gag-YFP. In the working model, it is hypothesized that UDMs 
carry Gag to the uropod. If so, the increased LZ4/Gag-YFP polarization suggests that 
UDM association and uropod localization occur early in assembly. Thus, it would be 
expected that the increased polarization of LZ4/Gag-YFP would correlate to a stronger 
UDM association than monomeric/, LZ2/ or LZ3/Gag-YFP. However, because these low-
order multimers do not form patches or puncta, the copatching assay performed with wild 
type Gag-YFP can not be used. Another method to determine whether LZ4/Gag-YFP 
associates with UDMs more than monomeric/, LZ2/ or LZ3/Gag-YFP is super resolution 
microscopy, which was recently optimized in collaboration with the Veatch lab to 
observe Gag and tetherin colocalization[33].  
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Super resolution microscopy is capable of 10-30nm resolution and thus, unlike 
conventional light microscopy, can observe microdomains in their native state[33, 52-
54]. This is accomplished by linking a protein of interest to a photo-switchable tag such 
as mEos2[55] or labeling a primary antibody with a fluorescent secondary antibody 
capable of reversible photobleaching such as Alexafluor647[56]. Total internal reflection 
fluorescence (TIRF) microscopy[57] can then be used to observe only the cell surface-
associated proteins. MEos2 switches between green and red fluorescence when 
stimulated by laser light and AlexaFluor647 switches between fluorescence and non 
fluorescence when stimulated by laser light in a reducing buffer. This “blinking” allows 
only a small subset of fluorophores to be observed in each image. Roughly 5000 images 
are then taken and compiled into a single image that pinpoints, to a high precision, the 
location of the fluorescent proteins. Cross correlation analysis, which calculates the 
likelihood of a protein being within a certain distance of another protein[58], can then be 
performed to determine whether the two proteins are associated with each other.  
TIRF microscopy requires that the observed cells are in contact with the glass 
coverslip because the excitation laser is set to slightly below the critical angle, which is 
the angle that causes total reflection of the laser when it reaches the coverslip/sample 
interface. Thus, the evanescent wave generated at the coverslip/sample interface only 
penetrates approximately 100 nanometers past the glass/media interface into the cells. 
This method has been previously used to study HIV-1 membrane association and 
assembly[59-62]. Because of the necessity of cell adherence to the coverslip, the first 
experiments would be conducted using mEos2-tagged constructs in HeLa cells, which 
have been used previously for super resolution microscopy by Grover et. al[33]. In 
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contrast to HeLa cells, T cells are non-adherent, making TIRF difficult to achieve. 
However, developing this assay to observe Gag-mEos2-derived mutants in T cells may 
also be possible if T cells can be adhered to glass coverslips. For example, coating 
coverslips with either poly-L-lysine or fibronectin can promote T cell adherence to 
coverslips. If the adherence generated by this method does not significantly alter T cell 
morphology, then super resolution microscopy could be used to observe the level of 
association between  UDMs and monomeric/, LZ2/, LZ3/ and LZ4/Gag-mEos2 in the 
more biologically relevant T cells. 
If LZ4/Gag-mEos2 was observed to associate with UDMs to a higher degree than 
monomeric/, LZ2/ or LZ3/Gag-mEos2 in either HeLa or T cells, it would support the 
hypothesis that UDM association occurs early in assembly and that UDMs carry Gag to 
the uropod. However, if monomeric/Gag-mEos2 is observed to associate with UDMs as 
effectively as LZ4/Gag-mEos2 and at similar levels as wild type Gag-mEos2, it would 
also indicate that UDM association occurs early in assembly but that UDM association by 
itself does not drive uropod localization. Finally, if UDM association is observed for the 
wild type Gag-mEos2 control but not observed for LZ4/Gag-mEos2 or other LZ mutants, 
it would indicate both that UDM association is not required for uropod localization and 
that UDM association occurs later in assembly. 
 
What are the dynamics of assembly, localization and UDM association of Gag in 
polarized T cells?  
The above experiments would provide compelling evidence for when Gag 
association with UDMs occurs. However, the results would be based on fixed cells, 
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which represent a static snapshot of the processes that are occurring. Thus, they do not 
reveal the dynamics of when UDM association occurs relative to uropod localization. To 
examine the dynamics of these processes, live cell TIRF analyses could be used in 
conjunction with a drug-inducible Gag multimerization mutant. This assay could be used 
to determine where and when de-novo assembly of Gag and UDM association occur in 
polarized T cells and the relationship between UDM association and uropod localization.  
 The drug-inducible Gag multimerization mutant was constructed by replacing CA 
with a dimerization motif derived from the variant FKBP protein (VF1) (CA/VF1/Gag-
YFP). VF1 dimerization is induced by the addition of a small molecule drug, AP20187. 
Thus, when AP20187 is added, CA/VF1/Gag-YFP multimerizes (Fig. 4.6A). This was 
observed in a preliminary experiment showing that CA/VF1/Gag-YFP was mostly 
cytosolic before the addition of AP20187 (Fig. 4.6B), likely due to a membrane binding 
defect caused by a lack of multimerization. However, 30 minutes or longer after the 
addition of AP20187, CA/VF1/Gag-YFP was observed to localize on the plasma 
membrane and to uropods in the majority of cells (Fig. 4.6C), indicating a restoration of 
multimerization. These results are quantified in Fig. 4.6D. If the experiments utilizing 
super resolution microscopy in T cells described in the previous section are successful, 
the same technique could be applied to living cells. T cells expressing CA/FV1/Gag-
mEos2 could be immunostained for PSGL-1 or other UDM proteins with an Fab antibody 
fragment conjugated to AlexaFluor647. After the addition of AP20187, images could be 
taken over 30min or 1hr. Unlike the previously proposed super resolution microscopy 
experiments of fixed cells, fewer pictures would have to be taken for each time point as 
living cells may migrate. Thus, some resolution would be sacrificed. However, the 
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resolution would still be enough to resolve single virus particle formation and UDM 
recruitment over time. This experiment would allow real time observation of whether 
forming Gag particles recruit UDM markers before or after they begin migrating to the 
uropod. Another possibility is that virus particles preferentially begin forming at the 
uropod in already polarized cells. Thus, these experiments could provide novel 
observations about the dynamics of how, when and where Gag assembly and UDM 
association occurs in polarized T cells.  
 
Perspective 
The research presented in this thesis could be used to expand our understanding of 
retrovirology in general. For example, HTLV-1 is another retrovirus that replicates in T 
cells. Like HIV-1, HTLV-1 Gag is thought to multimerize on the plasma membrane. 
Thus, based on the work presented in this thesis, HTLV-1 Gag could also localize to 
uropods in polarized T cells. Similarly to HIV-1, HTLV-1 spread is also primarily 
mediated through cell-to-cell transmission. Moreover, it was recently found that the 
uropod marker CD43 enhances cell-to-cell transmission of HTLV-1 [63]. These 
observations are consistent with the possibility that uropods are also important for the 
spread of other retroviruses. Thus, future studies could determine whether uropod-
mediated cell-to-cell transmission represents a common mode of transmission for viruses 
that bud from polarized lymphoid cells.  
  In the context of HIV-1, further studies on the role of uropods for transmission of 
HIV-1 between other cell types would also broaden our understanding of HIV-1 spread in 
vivo. For example, dendritic cells are another target cell of HIV-1. It is conceivable that 
 157 
uropods of uninfected T cells could also mediate contact with HIV-1-infected dendritic 
cells. If such uropod-mediated contact was observed, it would be consistent with the 
possibility that uropods not only play a role in transferring virus particles to target cells 
but also act as a site of virus entry. Similarly, investigating whether uropods play a role in 
cell-to-cell transmission between T cells and macrophages could also enhance our 
understanding of HIV-1 spread between the natural targets of HIV-1 in vivo.  
The outcomes of future studies on the mechanisms of uropod localization and 
UDM association described in this chapter could also provide opportunities to examine 
the role of uropods in HIV-1 spread in vivo. For example, it could be found that uropod 
localization or UDM association of HIV-1 is dependent on a particular uropod protein, 
such as PSGL-1 or CD43. If this were found, human hematopoietic stem cells could be 
engineered to not express this protein and then used to generate humanized mice. These 
humanized mice would then contain human T cells that are polarized but do not 
concentrate HIV-1 at their uropods when infected. These humanized mice could then be 
used to study HIV-1 spread when HIV-1 does not localize to uropods in an in vivo 
context. If an interaction between Gag and a uropod protein was found to be important 
for spread of the virus in vivo, this humanized mouse system could also be used to test the 
therapeutic value of small molecule drugs that target this interaction.   
 
Conclusion 
Generally, the goal of science is to understand, at a fundamental level, the ways in 
which life and the world work. In the case of HIV-1 research, we strive to understand the 
details of how HIV-1 replicates and spreads within the human body. The strength of the 
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findings presented in this thesis are that they define mechanisms of HIV-1 localization 
and spread in T cells that are in the same biologically relevant, morphologically polarized 
state as most T cells in lymphoid organs. Thus, the observations that HIV-1 localizes to 
uropods in polarized cells and that uropods play a role in cell-to-cell transfer of virus 
particles, represent significant steps forward in our understanding of how HIV-1 is 
transmitted between T cells in vivo. The observations that multimerization is required for 
polarized localization and that MA determines the association of Gag with specific 
microdomains also represent new insights into the relationship between HIV-1 and the 
plasma membrane in biologically relevant polarized T cells. Therefore, these studies 
represent significant progress towards an ever deepening understanding of HIV-1 and 
how it operates within the human body. 
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Figure 4.1. CD4-YFP promotes infection by HIV-1. 
An expression plasmid encoding CD4-YFP was transfected into A) HeLa cells by 
lipofectamine or into B) P2 cells by amaxa nucleofection. C) HeLa cells expressing 
vector without CD4, or untagged CD4 or YFP-tagged CD4 were uninfected or mock 
infected with pNL4-3 virus particles. Two days post infection, p24 levels were measured 
by flow cytometry. 
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Figure 4.2. Experimental flow chart. 
This flow chart outlines the experiments required to determine whether Gag/YFP 
activates PSGL-1 that then increases cell-cell transfer of virus particles by signaling 
LFA-1 to become more adhesive to its binding partners.  
 
Knock down PSGL-1 in donor P2 cells and determine whether cell-cell transfer of Gag/YFP is enhanced
If yes:Test whether GagYFP
induces LFA-1 activation.
If No:Test other UDM proteins
If yes:Test whether Gag-mediated LFA-1
activation is due to PSGL-1 by knocking down
PSGL-1 and testing for LFA-1 activation in
Gag-YFP-expressing cells
If no:  Indicates PSGL-1 increasescell-cell transfer of
virus particles due to it ’sown adhesive properties
If no: Indicates LFA-1 is activated by Gag through
another mechanism. Test other viral proteins.
If yes:Test whether LFA-1 also enhancescell-cell
transfer of virus particlesby shRNAknockdown.
If no: Indicates LFA-1 activation is a side effect of
Gag-mediated PSGL-1 activation, but does not
enhance virusreplication.
If yes: Confirm the model by measuring cell-cell
transfer efficiency when both PSGL-1 and LFA-1 are
knocked down in donor Tcellscompared to single
knockdwonsto determine whether PSGL-1 and LFA-1
individually enhance cell-cell transfer or whether both
are eqally required.
Model: HIV-1 Gag crosslinks PSGL-1, which activates LFA-1 that then
          enhancescell-cell transfer of virus particles.
Experimental Flow Chart
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Figure 4.3. HeLa cells do not express PSGL-1 unless transfected. PSGL-1 in 
transfected HeLa cells copatch with Gag.  
A) HeLa cells were transfected with Gag-YFP and immunostained by copatching for 
PSGL-1. B) HeLa cells were transfected with pCMV6-AC-PSGL-1 and immunostained 
for PSGL-1 by copatching. C) HeLa cells were transfected with both Gag-YFP and 
pCMV6-AC-PSGL-1 and immunostained for PSGL-1 by copatching.  
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Figure 4.4. CD43/PSGL-1/CD44-enriched UDMs pre-exist, but also include ICAM-
3. 
Uninfected P2 cells were co-immunostained by copatching assay for CD44 and UDM 
proteins utilizing isotype specific secondary antibodies. A) As a positive control, CD44 
copatches with itself. B) CD44 also copatches well with CD43 and C) PSGL-1. D) CD44 
segregates from ICAM-1. E) CD44 also copatches with ICAM-3. F) Images taken of the 
tops of cells were quantified using the Pearson’s coefficient. Error bars represent SEM.  
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Figure 4.5. CD44/ICAM3 copatching is lost in the presence of Gag-CFP. 
P2 cells were infected with VSV-G pseudotyped viral particles encoding Gag-CFP. Cells 
were immunostained by copatching and the tops of cells were imaged for A) CD44(IgG1) 
and Gag-CFP (red in the merged image) and B) CD44(IgG1) and ICAM-3(IgG2B). The 
image for (A) and (B) are of the same cell. C) Quantification of copatching was done 
using Pearson’s coefficient. The first and fourth columns were quantified from the same 
Gag-CFP expressing cells immunostained for both ICAM-3 and CD44, while the second 
column was quantified from cells expressing Gag-CFP and only immunostained for 
ICAM-3, and the third column was quantified from uninfected cells immunostained for 
ICAM-3 and CD44. 
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Figure 4.6. Drug inducible multimerization system. 
A) Illustration of AP20187 induced multimerization of Gag containing the FV1 
dimerization motif in place of CA (CA/VF1/Gag-YFP). B) P2 cells were infected by 
VSV-G pseudotyped virus particles encoding CA/VF1/Gag-YFP. 2 days post infection 
CA/VF1/Gag-YFP is observed in the cytoplasm but not on the membrane (left panel), 
but after 30 minutes of AP20187 treatment, CA/VF1/Gag-YFP is observed on the 
plasma membrane. C) Quantification of the percentage of observed with CA/FV1/Gag-
YFP on the membrane with or without AP20187 treatment. n=number of cells quantified. 
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